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The ocular surface provides a unique opportunity to study hemodynamics since the vessels can 
be visualized directly, without treatment and non-invasively. The availability of instruments to 
measure various hemodynamic parameters on the ocular surface in an objective manner are 
lacking. The quantification of red blood cell velocity, blood oxygen saturation and conjunctival 
redness on the ocular surface using novel, validated techniques has the potential of providing 
useful information about vascular physiology.  
The specific aims of each chapter are as follows: 
Chapter 3: The objective was to design, develop and validate a system that would non-invasively 
quantify the red blood cell velocity in the conjunctival vessels. A tool was developed to 
automatically analyze video sequences of conjunctival vessels, digitally imaged with high 
enough magnification to resolve movement of the blood within the vessel. 
Chapter 4: The objective was to: a) design and develop a method in order to non-invasively 
quantify the changes in blood oxygen saturation (SO2) in the conjunctival vessels and 
demonstrate reliability of the measures and, b) demonstrate the application of the method by 
showing a response to an isocapnic hyperoxic provocation and compare those values to the 
results from a valid instrument. 
Chapter 5: The aim of this experiment was to examine variations in ocular redness levels, red 
blood cell velocities and oxygen saturation levels over time in clinically healthy participants and 
also to compare differences between two age groups. 
Chapter 6: The aim of this experiment was to examine the ocular redness levels, red blood cell 
velocities and oxygen saturation levels in clinically healthy participants when a topical 
ophthalmic decongestant was instilled onto the eye and to demonstrate the validity of the use of 
two novel techniques. 
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Chapter 7: The aim of this experiment was to examine ocular redness, red blood cell velocity and 
oxygen saturation in participants who were habitual soft contact lens wearers (study) compared 
to those that did not (control) and also to compare differences in silicone (SH) and non-silicone 
hydrogel wearers. 
Methods 
Chapter 3: Simulations representing moving RBCs within a vessel and the random variation of 
each cell in terms of speed, shape and intensity were created in order to evaluate the performance 
of the algorithm. For each vessel, a signal that correlated to blood cell position was extracted 
from each frame, and the inter-frame displacement was estimated through a modified dynamic 
time warping (DTW) algorithm. This provided the red blood cell velocity over time in each point 
of the vessels. Thus, from these estimates, the mean red blood cell velocity for each vessel was 
easily evaluated. The true mean velocity from the simulation with the one estimated by the 
algorithm was compared and the system accuracy was determined. 
Chapter 4: a) Conjunctival vessels were imaged with two narrow-band interference filters with 
O2-sensitive and O2-insensitive peak transmissions using a Zeiss slit lamp at 32x magnification. 
Optical densities were calculated from vascular segments using the average reflected intensities 
inside and outside the vessels. Optical density ratios were used to calculate relative oxygen 
saturation values. Video images of the bulbar conjunctiva were recorded at three times of the 
day. Measurement repeatability was assessed over location at each time and across consecutive 
frames. b) Subjects initially breathed air for 10 minutes followed by pure oxygen (O2) for 20 
minutes, and then air for a final 10 minute period using a sequential re-breathing circuit. 
Simultaneously, SO2 values measured with a pulse oximeter ear clip and finger clip were 
recorded. The validity of the dual wavelength method was demonstrated by comparing the values 
to those from the ear clip pulse oximeter. 
Chapter 5: Participants attended eight separate visits over the course of a day. Levels of bulbar 
conjunctival redness, red blood cell velocity and blood oxygen saturation were measured on a 
vessel of interest. 
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Chapter 6: Participants attended three separate visits during an allotted 60 minute session. Bulbar 
conjunctival redness, red blood cell velocity and blood oxygen saturation were measured on a 
vessel of interest, pre-insertion, just after insertion and, 10 minutes after insertion of a topical 
ocular decongestant. Significant differences between the three measures were assessed and 
correlations between the three parameters were reported. 
Chapter 7: Participants were measured 8 times over the course of a day with their contact lenses 
in place. Bulbar conjunctival redness, red blood cell velocity and blood oxygen saturation were 
measured. 
Results 
Chapter 3: Results for the simulated videos demonstrated a very good concordance between the 
estimated and actual velocities supporting its validity. The mean relative error for the modified 
Dynamic Time Warping (DTW) method is 6%. 
Chapter 4: The intraclass correlations (ICCs) between the three locations at each time point were 
0.93, 0.56 and 0.86 respectively. Measurements across 5 consecutive frames showed no 
significant difference for all subjects (ICC = 0.96). The ICCs between the two methods at each 
time point were 0.45, 0.10 and 0.11 respectively. a) There was no significant difference in SO2 
between the three locations measured using the dual wavelength method for all subjects. There 
was also no significant difference between the three locations at any of the time points for the 
dual wavelength method. b) In response to isocapnic hyperoxic provocation using the dual 
wavelength method, blood oxygen saturation was increased from control values and 
subsequently recovered after withdrawal of hyperoxia. Blood oxygen saturation values recorded 
from the ear clip and finger clip of the pulse oximeter also showed an increase from control 
values and subsequently recovered after withdrawal of hyperoxia. SO2 comparison between the 
dual wavelength method and the ear-clip pulse oximeter method did not show a significant 
difference. The interaction between the two methods and time on SO2 was not significant. 
Chapter 5: From baseline, the group mean redness and oxygen saturation did not change 
significantly over time. There was a significant difference in the group mean red blood cell 
 
vi 
velocity values over time. There was no significant difference between age strata for all three 
measures.  
Chapter 6: After drop instillation redness values decreased significantly. There was no change in 
red blood cell velocity and oxygen saturation over time. There was a moderate significant 
correlation between SO2 and red blood cell velocity just after drop insertion. 
Chapter 7: When comparing the study and control groups, no significant difference in redness or 
SO2 over time was found. RBC velocity over time was found to be significantly different 
between groups. When comparing the two study groups (SH vs. hydrogel) no significant 
difference across either measure over time was found.  
Conclusions 
Chapter 3: Signal displacement estimation through the DTW algorithm can be used to estimate 
mean red blood cell velocity. Successful application of the algorithm in the estimation of RBC 
velocity in conjunctival vessels was demonstrated. 
Chapter 4: The application of the dual wavelength method was demonstrated and optical density 
ratios can be used in a reliable manner for relative oxygen saturation measurements. This valid 
method promises to enable the study of conjunctival O2 saturation under various experimental 
and physiological conditions. 
Chapter 5: The results of this study support the theory of metabolic regulation. The lack of any 
significant change across time for redness and oxygen saturation along with significant changes 
in red blood cell velocity substantiates this notion.  
Chapter 6: This study supports the literature regarding metabolic regulation of the 
microvasculature during the use of various stimuli. The results demonstrated that oxygen 
saturation levels remain stable even when a significant decrease in ocular redness is measured. 
The novel techniques used in this experiment demonstrated the expected action of the 
decongestant further contributing to their application and validity. 
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Chapter 7: In summary, the participants in the study group were habitual contact lens wearers 
that had lower RBC velocities when compared to the control group supporting the notion that 
contact lenses initiate a hypoxic response. The lack of change in SO2 in either group supports the 
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1.  Introduction 
1.1 Systemic Circulation 
The segment of the cardiovascular system which carries oxygenated blood away from the heart, 




Oxygenated blood is circulated to the tissues via the arteries in this system. As the oxygenated 
blood circulates through the body, the oxygen diffuses into cells surrounding the capillaries and 
at the same time, carbon dioxide diffuses into the blood from the capillary cells.
1
 The veins are 
responsible for returning the deoxygenated blood back to the heart. 
1.1.1 Arteries1 
Systemic arteries are subdivided into two types; muscular and elastic. The larger arteries (more 
than 1cm in diameter) are generally elastic and the smaller ones (between 0.1-10mm) tend to be 
muscular. Systemic arteries transport blood to the arterioles, and then to the capillaries, where 
oxygen, carbon dioxide and other gases are exchanged. 
When oxygenated blood leaves the left ventricle of the heart, it enters the systemic circulation. 
The systemic circulation begins with the aorta, a massive and thick-walled artery. Numerous 
major arteries are given off from the aortic arch and go on to supply the upper body. Branches 
that stem from the diaphragm supply the lower parts of the body. 
1.1.2 Capillaries1 
The capillary network is where important exchanges happen in the circulatory system. 
Capillaries are the smallest of the body‟s blood vessels, measuring 5-10 µm. The capillaries have 
walls that are composed of a single layer of cells (the endothelium). This layer is so thin that 
molecules such as oxygen, water and lipids can pass through them by diffusion and enter the 




The capillaries are the most numerous of the blood vessels and receive blood from the arteries. 
Capillaries join tissue with arterioles for the movement of oxygen and nutrients to the cells.  
The network of capillaries that supply an organ is termed a capillary bed. The more 
metabolically active the organ, the greater number of capillaries it requires to supply it with 
nutrients.
2
 The capillary bed only carries a fraction of the amount of blood it could, although this 
percentage can be increased through regulatory mechanisms, inducing smooth muscle relaxation 
and constriction of the smaller arterioles downstream.
2
 
The capillaries do not include smooth muscle in their walls and therefore molecule exchange is 
passive.
3
 If signalling molecules are released (e.g. endothelin for vasoconstriction or nitric oxide 




The systemic cycle is completed when the deoxygenated blood is collected by the venules, flows 
into the veins, into the inferior and superior vena cavae and back to the right heart. Blood re-
enters the systemic circulation after it is re-oxygenated via the pulmonary circulation. 
1.1.4 Veins1 
The venous system collects the de-oxygenated blood and then branches into two major veins: the 
superior vena cava and the inferior vena cava. The right atrium of the heart is where these two 
major veins enter the systemic circulation.  
1.2 Circulation of the Head and Neck 
The upper systemic circulatory loop circulates blood to the head and neck regions.
1,4,5
 This loop 
originates at the aortic arch and includes the brachiocephalic artery, left common carotid and left 
subclavian artery.
1,4,5




1.2.1 Blood Supply1,4,5 
The right common carotid artery and the right subclavian artery are the first branches off of the 
brachiocephalic artery. The next branch (vertebral artery) provides blood to the right upper chest, 
 
3 
right arm, neck, and head. The vertebral artery then feeds into the basilar artery and the posterior 
cerebral artery and is responsible for providing most of the brain with oxygenated blood.  
The left common carotid artery branches into the internal carotid (ICA) and the external carotid 
arteries (ECA) which supply the brain and the neck and face respectively. 
1.2.2 Blood Brain Barrier 
The circulatory system is protected by the blood-brain barrier (BBB) which is a semi-permeable 
membrane that controls the capillary leak potential.
6
 In most parts of the body endothelial cells 
line the capillaries.
4,5
 Endothelial tissue allows substances to move easily between the inside and 
the outside of the vessel via the small spaces that are between each individual cell.
4,5
 Conversely, 
in the brain, substances cannot pass out of or into the bloodstream since the endothelial cells fit 
tightly together to create a tight junction.
4,5
 Other transport methods, such as active transport, 
assist in the transport of some molecules (e.g. glucose) out of the blood.
6
 
1.2.3 Ophthalmic Artery4,8 
The major artery of the head and neck that helps supply the brain is the internal carotid artery.
7
 
One of the branches of the internal carotid artery is the ophthalmic artery. The ophthalmic artery 
supplies the eye and other structures in the orbit. Along with the optic nerve, the ophthalmic 
artery enters the orbit via the optic canal.
9
 The branches of the ophthalmic artery are subdivided 
into the orbital and ocular groups. 
1.2.4 The Ocular Group4,8 
The ocular group is responsible for the distribution of vessels to the eye and its surrounding 
muscles. The ocular group includes the posterior ciliary arteries (long and short) and branches 
into two systems: the retinal supply and the uveal tract/ciliary body. 
 
1.2.4.1 The Retinal Supply4,8 
The central retinal artery enters inferior to the optic nerve 10mm posterior to the back of the 
eyeball in conjunction with the venous drainage exit and the central retinal vein. It pierces the 
optic nerve close to the eyeball, sending terminal branches over the internal surface of the retina 
 
4 
and is a major blood supply to the larger part of it. The branches develop to form continuous 
loops of arterioles flowing into venules with very few retinal anastomoses. Avascular areas form 
around the arterioles because of sufficient oxygen availability from freely diffusing oxygen. 
The retinal arteries distribute blood to the inner two-thirds of the retinal depth while the 
remaining outer layers (e.g. photoreceptors) are nourished by the choroidal supply.
9
 
The retinal areas are supplied by the uveal tract since they are in close proximity.
10
 
1.2.4.2 Ciliary Body/Uveal Tract 
The ciliary body and uveal tract supply blood to the iris, ciliary body, choroid, optic nerve head 
and give way to the short and long posterior ciliary arteries.
4,8
 
The short posterior ciliary arteries (SPCA) pass forward around the optic nerve to the posterior 
part of the eyeball, pierce the sclera around the entrance of the optic nerve, and supply the 
choroid (up to the equator of the eye) and ciliary processes.
4,8
 The SPCA‟s branch into the 
anterior and posterior choriocapillaris.
9
 
The long posterior ciliary arteries are arteries of the head and supply the iris, ciliary body and 
choroid.
4,8
 They pierce the posterior part of the sclera at some little distance from the optic nerve, 
and run forward, along either side of the eyeball, between the sclera and choroid, to the ciliary 
muscle, where they divide into two branches and form the major circle of iris with the anterior 
choriocapillaris that branch from the SPCA‟s.
9
 
1.2.4.3 Anterior Ciliary Arteries4,8 




The ACAs travel to the anterior portion of the eye alongside the extraocular muscles. The ACAs 
and the extraocular muscles form a vascular area underneath the conjunctiva, and eventually 
meet with the sclera a short distance from the cornea. 
1.2.4.4 Conjunctival blood supply 
The circulation of the conjunctiva can be divided into two portions, the peripheral and the central 





 The central bulbar conjunctiva/limbal area is supplied by the anterior 
conjunctival branches of the anterior ciliary arteries (superficial) and the long posterior ciliary 
arteries (deep).
11
 The anterior ciliary arteries branch toward the cornea from the ophthalmic 
artery to form a superficial plexus, the episcleral arterial circle
12
.  
As described by Bloch
13
, there are two branches from the ophthalmic artery that supply the 
central bulbar conjunctival/limbal portions of the eye. One branch is responsible for superficial 
circulation and the other, deeper circulation. Both branches form the anterior ciliary arteries.
4,8
 
These arteries advance into the corneo-scleral junction (episcleral arterial circle) and then help 
form the intra-ocular arterial circle along with the long posterior ciliary arteries
14
. Many sets of 
capillaries branch from the episcleral circle at this point then run parallel to the corneo-scleral 
margin. From this point, the plexus divides into its connected superficial and deep layers 
responsible for the circulation
15
. 
The posterior component is responsible for supplying blood to the iris and the ciliary body 
12
. 
The superficial component is a branch that forms the episcleral arterial circle
12
. Branching from 
the circle are 2 types of vessels, the first set of vessels form limbal arcades and the second set of 
vessels supplies the superficial conjunctiva.
4,8
 
There are also communicating vessels that connect the intra-ocular arterial circle with the 
episcleral arterial circle, allowing for communication routes in the anterior eye
12
. 
1.3 Structure of Ocular Vessels 
The arteries and veins have the same basic structure. There are three layers, from the inside to 
the outside (endothelium, smooth muscle cells, adventitia).
4,8
 Conversely, the capillaries are only 
one cell layer thick.
1
  
Capillaries consist of little more than a layer of endothelium and occasional connective tissue.
4,8
 
The endothelium in the capillaries is associated with a basement membrane which contains 
pericytes.
4,8











1.3.1 Tunica intima (the thinnest layer) 
The tunica intima is a single layer of simple squamous endothelial cells joined by an intercellular 
matrix, surrounded by a thin layer of sub endothelial tissue connected with a number of 
circularly arranged elastic bands called the internal elastic lamina.
2
  
There are three types of endothelial cells that line the interior of blood vessels depending on the 
location and function of the vessel.
2,4,8
 
1.3.1.1 Continuous endothelial cells 
Continuous endothelial cells are the most prevalent type found in the walls of arterioles, 
capillaries and venules of skeletal, smooth and cardiac muscle, skin mesentery, connective tissue, 
retina, brain, lung and lining of major conduit vessels.
2
 These endothelial cells are characterized 
by occluding tight junctions and provide an impermeable barrier to large molecules.
2
 
1.3.1.2 Fenestrated endothelial cells  
Fenestrated endothelial cells are found mainly in exchange vessels of secretory and excretory 






1.3.1.3 Discontinuous endothelial cells 
Discontinuous endothelial cells are characterized by relatively large “openings” and are highly 
permeable. The capillary bed of the liver is an example of where these cells may be found.
2,4,8
 
1.3.2 Tunica media (the thickest layer) 
Circularly arranged elastic fibre that separates the second and third layer is the external elastic 
lamina.
2,4,8
 The tunica media may (especially in arteries) be rich in vascular smooth muscle, 
which controls the calibre of the vessel.
2,4,8
  
1.3.3 Tunica adventitia 
This outer layer is entirely made of connective tissue and contains numerous fibroblasts.
2,4,8
 It 




1.4 Blood Flow 
The flow of blood in the cardiovascular system and the study of it through vessels and vascular 
networks occupies an important place in physiology. Blood flow (Q) is equal to a change in 
pressure (∆P) with respect to resistance (R).
17
 The pressure difference is generally expressed as 
the difference between the arterial pressure and venous pressure and the resistance is the 
resistance to flow that is related in large part to the size of the valve opening.
18-20
 Blood flow is 
readily described partially by Ohm‟s law and partially by Hagen-Poiseuille‟s law since Ohm‟s 
law is only accurate for Newtonian fluids.
17-21
 The combination and use of the two laws help our 
understanding of the vast arrays of physiological phenomena. Blood is a non-Newtonian fluid 
whose viscosity varies with flow rate or rate of shear and its flow can be described as laminar 
only in the small vessels; elsewhere it is turbulent.
18-20
  
  Q = [∆P/R]
18-20




and,   υ = dynamic viscosity 
       L = the length of the tube/vessel  




It is important to note that with Poiseuille‟s equation, blood flow changes with the fourth power 
of the radius and therefore increases in blood flow can be achieved with small increases in vessel 
radius.  
There are several rheological complexities that remain present given the non-Newtonian nature 
of blood and therefore caution should be used when interpreting results that are present in the 




There has been some on-going success in quantifying the rheological behaviour of blood in vitro 




1.4.1 Blood Pressure 
Blood pressure is the force exerted on the walls of blood vessels by the circulating blood and 
generally refers to arterial pressure.
4,5,22
 As blood moves through arteries, arterioles, capillaries, 
and veins, the pressure of the blood decreases.
4,5,22
  
Systolic pressure is the peak pressure in the arteries, occurring near the beginning of the cardiac 




A healthy adult human typically has a resting blood pressure of approximately 120 mmHg 
systolic and 80 mmHg diastolic.
4,5
 Arterial pressure values are not static and undergo natural 
variations throughout the day (circadian rhythm) and from heartbeat to heartbeat.
4,5
 Blood 
pressure measures can also change in response to stress, nutritional factors, drugs, or disease.
4,5
 
1.5 Ocular Blood Flow Measurement Techniques 
Blood flow measurement of any circulatory path can be quite difficult since blood is a non-
Newtonian fluid and its viscosity constantly changes.
23
 Non-Newtonian fluids have distinctive 
characteristics, such as pulsatile flow.
23,24
 The elastic nature of the vessels allows them to change 
 
9 
their shape and diameter in order to accommodate changes in circulation.  When measuring 
blood flow, there are many factors that have to be considered. Some of the factors are patient 
history, surrounding conditions, temperature, blood pressure, medications, state of the red blood 




There are a few articles demonstrating the usefulness of using the measurement of bulbar 





Most articles dealing with the measurement of blood flow in the conjunctiva do not measure it 











Blood flow measurement of the retina is much more common. There are numerous publications 
that deal with various aspects of quantitatively and qualitatively measuring the blood flow of the 
posterior eye.
30-37
 These techniques available for these tasks are sometimes used in combination 
to aid in the complete understanding of ocular hemodynamics.  
1.5.1 Scanning Laser Ophthalmoscopy 
Scanning laser ophthalmoscopy is used to measure erythrocyte and leukocyte velocity in the 
retina and is often used for measurements in perimacular retinal capillaries. The scanning laser 
ophthalmoscope is a confocal laser instrument with good spatial resolution and is capable of 
producing images with good contrast.
30,31
 Reflected light intensities exiting the eye via the pupil 
pass through a confocal aperture and proceed to a detector.
30,31
 Any light scattered outside the 
focal plane is blocked by the aperture.
30,31
 
1.5.2 Colour Doppler Imaging 
Colour Doppler Imaging (CDI) is used to measure extraocular blood velocities in primarily the 
central retinal artery, posterior ciliary arteries and the ophthalmic artery. CDI includes  
ultrasound techniques that combine b-scan grayscale imaging of tissue structure, and colour 





1.5.3 Pulsatile Ocular Blood Flow  
Pulsatile ocular blood flow is a representation of the pulsatile component of arterial inflow to the 
eye achieved from the intraocular pressure pulse.
33,36
 Subsequently, the volume and the IOP are 
highest during systole and lowest during diastole.
33-36
 Methods have been used to measure the 
pulse wave of the rhythmic changes in IOP during the cardiac cycle.
35,36
  The ocular pulse and 
the amplitude of the IOP pulse wave are recorded for use in calculating the change in ocular 
volume and consequently the pulsatile component of blood flow.
33
 Since the greater percentage 
of ocular blood flow is part of the choroidal circulation, this technique is regarded as a 
representation of choroidal blood flow and not the retinal circulation. 
1.5.4 Laser Doppler Velocimetry and Flowmetry 
Bi-directional laser Doppler velocimetry (LDV) is used to measure blood velocity in the main 
retinal vessels. This method provides data on a single vessel and therefore no information about 
the perfusion of the rest of the eye.
33
 The velocity of the red blood cells is calculated from an 
analysis of Doppler shifts observed in the light that is scattered by them in real time.
38
 This 
velocity is then combined with a measure of the vessel diameter (measured by micrometry) to 
obtain an estimation of flow.
37
 An instrument that used this method is the Canon Laser Doppler 
Flowmeter 100 (CLBF). The CLBF uses a tracking device and the Bi-directional Laser Doppler 
Velocimetry principle to monitor changes in retinal blood vessel diameter, velocity and blood 
flow.
39-42
 Since the CLBF is also capable of recording retinal vessel diameter it is therefore, able 
to derive blood flow in real units.
40
 
Laser Doppler flowmetry (LDF) is somewhat similar to laser Doppler velocimetry, but it is able 
to calculate blood flow rather than just blood velocity. This method provides information on 
capillary blood flow at a specific location over a specific period in arbitrary units.
33
 The 
Heidelberg Retina Flowmeter (HRF) is an example of this technique using confocal scanning 
laser Doppler flowmetry to provide a 2-dimensional map of the retinal micro-circulation.
30,31,33
 
The HRF provides a non-invasive, continuous measure of microcirculatory blood flow by 
recording the frequency change that light undergoes when reflected by moving red blood cells 
within the capillaries.
41
 The possible parameters that can be measured and quantified are blood 
flow, blood velocity and blood volume.  Due to limitations with this device, the HRF is only 





Previous studies have also utilized this method for the anterior surface, measuring relative blood 
flow values in the capillaries of the bulbar conjunctiva.
45
 
1.5.5 Fluorescein Angiography 
Angiographic techniques allow for the visualization of anatomic structures by the passage of 
sodium fluorescein and therefore, quantification of blood flow in the retina.
46
 Initially these 
angiograms were used to gather qualitative characteristics and information about the vascular 
anatomy and integrity within the eye. More recently the approaches include an attempt to obtain 
a level of quantitative information.  Even though these techniques cannot measure blood flow, 
they do however provide valuable information on the effect of ocular disease in the retina.
46
 
1.5.6 Retinal Vessel Diameters  
The above techniques are limited by the fact that they are only capable of directly measuring 
blood velocity and not blood flow. As an example, if information about vessel diameter is absent, 
results showing an increase in blood velocity should be interpreted with caution. The apparent 
increase in velocity could foreseeably be as a result of an increase in blood flow or conversely a 
resultant vasodilation of the vessel.
47,48
 Therefore, in order to determine blood flow, vessel 
diameter quantification is crucial. Many techniques have been used for this purpose and they 




1.5.7 Laser Interferometry 
Interferometry measures changes in corneo-retinal distance during the cardiac cycle and is used 
in the hemodynamic assessment of the choroid. As blood enters the eye (systole) choroidal blood 
volume increases and axial length decreases.
49,50
 When a change in axial length occurs, the 
interference pattern (produced from a laser light directed along the pupillary axis and reflected 
from the cornea and the fundus) changes.
49,50
 The change in the interference pattern represents 
flow, but the relationship between flow and pulsation is not known and therefore is only 






1.5.8 Video Cameras and Cell Tracking 
Video recordings of red blood cell flow through capillary networks offer an enormous amount of 
information relating to the microcirculation and image analysis
51,52
 of those videos have been 
used as a method to monitor and calculate blood cell velocity.
51,53-57
 
With this method, recordings of capillary networks are made using video microscopy. Various 
capillary networks have been used including the rat extensor digitorum longus muscle
56
, cheek 
pouch retractor muscle of hamsters
58
 and the retina
55
. Although types and models between 
groups vary, the images are recorded using a video camera/recorder with multiple 
magnifications. An addition to the system usually includes an interference filter (approximately 
421nm) that is used to enhance red blood cell (RBC) contrast. Video processing is then 
performed with various software systems to track specific RBC sequences. One group in 
particular developed an automated method to track RBCs as they traversed capillary networks 
and then analyzed the recordings using a space-time imaging technique.
51,58
  
 These methods provide a means to study changes in flow patterns over time and in response to 
various stimuli or disease states. In addition, by varying the length of time corresponding to each 
processed image, various characteristics of RBC flow within a network (e.g. local or global 
changes) can be determined. 
1.6 Blood Flow Regulation 
Regulation of blood flow (homeostasis) is necessary to adapt to different internal and external 
conditions. Circulation provides transport to a large variety of molecules, including oxygen and 
cells such as leukocytes.
33,34
 The regulation of blood flow also compensates for varying 




Blood flow in an organ is regulated by perfusion pressure and local resistance to flow.
4,34
 Local 
resistance is controlled by the calibre of the vessels. Among other things, the autonomic nervous 









1.6.1 Retinal Blood Flow Regulation 
In the retina, the regulation of blood flow is determined by perfusion pressure and the diameter 
of retinal vessels.
8,34
 Local myogenic responses, metabolic factors and endothelial derived 
substances influence vascular resistance.
8,59
  Retinal blood flow is regulated through 
modifications of vascular resistances (i.e. changes in the contractile state of retinal arterioles).
8,34
 
Retinal blood flow is fairly constant despite moderate variations in perfusion pressure and 
therefore, the partial pressure of O2 (PO2) is maintained at constant values in the inner retinal 
tissue during moderate reductions of perfusion pressure.
8,34,59
 
1.6.2 Choroidal Blood Flow Regulation 
The conjunctiva is supplied by the long posterior ciliary arteries, branching from the ophthalmic 
artery and is part of the choroidal circulation.
11
 In contrast to retinal blood flow, choroidal blood 
flow is regulated and changes very little during sudden increases or decreases in blood 
pressure.
34,59
 Choroidal blood flow is innervated by the autonomic nervous system (sympathetic 
activity) and through consequent vasoconstriction is able to maintain constant blood flow.
4,5
  
Vessels are controlled by the vascular endothelial cells, which release vasoactive factors.
4,5
 
These factors include nitric oxide, which induces vasodilation, and endothelin-1, which induces 
vasoconstriction.
4,5
 Unlike in the retina (because of the blood-retina-barrier), these and other 
circulating molecules have direct access to smooth muscle cells and pericytes in the choroidal 
circulation because they can escape the fenestrations in the vessels.
33,34
 
When the perfusion and oxygen extraction of the vascular network is maximized, a drop in 
arterial pressure and flow lower the tissue PO2 and lead to relaxation of the larger arterioles and 
restoration of blood flow.
4,5
 Whether due to elevated metabolism or low blood flow, it has been 
suggested that a low PO2 in the tissue favours autoregulation.
4,5
  
Although there is not a substantial amount of work examining blood flow in the bulbar 





 There are 4 main aspects to the control of blood flow- metabolic, nervous, 
myogenic and humoral regulation
61
.  
1.6.3 Metabolic Control 
Local control is maintained by each individual tissue, based on the particular metabolic need of 
the tissue.
8,59,62
 Anatomically, blood enters the capillary bed via an arteriole and leaves via a 
venule. The network of arterioles branches (metarterioles) and then lead into the capillaries. The 
arteries and arterioles have a strong muscular coat whereas metarterioles have a weaker one.
63
 
The arteries and arterioles are also innervated by the sympathetic nervous system and therefore 
their contraction is limited to the strength of the signal transmitted by the nervous system.
8,59,62
 
The arterioles and the capillaries are sparsely innervated, and therefore contraction is locally 




Local control can be short term or long term. As detailed by Guyton
4
, the short term control is 
based on 2 theories and makes up about 75% of the regulation. First, the vasodilator theory, that 
suggests with increased tissue metabolism, there is less blood flow, oxygen and nutrients 
available.
4,5
 In a situation where this occurs, a vasodilator substance (e.g. carbon dioxide, 
adenosine, histamine, potassium, hydrogen, etc.) will be formed,
4,5
 causing dilation. The second 




Because the short term local control can cause either rapid spikes or dips in blood flow, an 
autoregulatory response is needed to maintain blood flow.
4,8,62
 There are again, 2 processes to 
describe the homeostasis that occurs after these immediate responses. The first is a metabolic 
theory and the second is a myogenic theory.
4,5
 The metabolic theory maintains that since there is 
a rise in blood flow, more nutrients and vasodilator substances will be cleared out of the tissue 
and therefore dilation will decrease and homeostasis will occur.
64
 The myogenic theory 
maintains that when dilation occurs, the vessel wall stretches.
4,5
 When the vessel wall is stretched 
the smooth muscle is signalled to contract and therefore, bring blood flow back to homeostasis. 
The triggered contraction from the smooth muscle also acts as a protective mechanism to prevent 





Aside from the short term control that occurs when the metabolic needs of the tissue change, 
there has to be some long-term, regular control.
23
 Long term control accommodates 
approximately 25% of the regulation. Long term control will compensate for any metabolic 
changes (increase or decrease) in the tissue.
24,65
 If arterial pressure drops, then the long term 
regulation will accommodate by either increasing the size or even the number of vessels present 
in the tissue.
24,65
 Because of the constant fluctuations in pressure, vessel size or number, the 
vasculature within the tissue is constantly changing.
23,66,67
 It is also important to note that if a 
tissue becomes ischemic or has an increased metabolic need, initiation of new vessel growth will 
occur, triggered by angiogenesis factors.
4,8
 These factors develop in the tissues and promote the 
growth of new vessels. 
1.6.4 Nervous Control 
Nervous control is utilized in situations where there is a requirement to increase or decrease 
blood flow. Nervous control can affect larger areas of the systemic circulation.
68
 The 
parasympathetic and sympathetic systems act on the vascular smooth muscle cells to aid in the 
blood flow demand requirement.
4,5,66,67
 When activated, the parasympathetic system causes the 
smooth muscle cells to relax, allowing the vessel to vasodilate via endothelial derived relaxing 
factors.
4,5,66,67
 Conversely, when the sympathetic system is activated, it causes the smooth muscle 
cells to constrict the vessel via α-adrenergic receptors.
66,67
  
The complexity of the nervous system does not end in its control of blood flow and circulation. It 
also controls impulses to the heart and brain which can either excite or inhibit various centres of 
the body.
4
 Its complexity is beyond the scope of this introduction and will not be discussed in 
detail.  
1.6.5 Myogenic Control 
Myogenic control keeps blood flow constant irrespective of changes in arterial pressure. This 
control is maintained through the vasoconstrictor fibres of the sympathetic system.
4
  The 
vasoconstrictor fibres within the vessel emit constant impulses that control the vasomotor tone, 
that is, the constant, slight contraction of the vessels.
63
 Norepinephrine is the substance that is 









1.6.6 Humoral Control 
Humoral control involves various types of factors that are dissolved in the blood, which cause a 
local increase, decrease or an overall change in flow.
4
 The vascular endothelium is the source of 
most of these substances and thus it remains important in blood flow regulation.
63
 There are 
many important humoral factors, some of which cause vasodilation or vasoconstriction, or even 
both, depending on the situation.  
Some of the important vasodilators include nitric oxide, prostacylin, bradykinin, histamine, 
serotonin, prostaglandins and, potassium, magnesium, sodium and hydrogen ions.
4,5
 
Some of the important vasoconstrictors include endothelin-I, vasopressin, angiotensin, 
Norepinephrine, epinephrine and, calcium and hydrogen ions.
4,5
 
1.6.6.1 Nitric Oxide 
Nitric oxide (endothelium derived relaxing factor) is biosynthesised endogenously by many cells 
in the body however, its production by vascular endothelium is particularly important in the 
regulation of blood flow. The endothelium (inner lining) of blood vessels uses nitric oxide to 
signal the surrounding smooth muscle cells to relax, thus resulting in vasodilation and increasing 
blood flow.
4,5,69
 Nitric oxide (NO) contributes to vessel homeostasis by inhibiting the contraction 
and growth of vascular smooth muscle cells, the aggregation of platelets, and the adhesion of 
leukocytes to the endothelium.
4,5
 Since NO has a very important role in vascular function, its 





Endothelins are proteins that cause blood vessel constriction and are mainly produced in the 
endothelium. Among the strongest vasoconstrictors known, endothelins have a primary role in 
vascular homeostasis and are implicated in vascular diseases of several organ systems, including 





There are four isoforms (ET-1, -2, -3, -4) with varying areas of expression and two key receptor 
types, ETA and ETB.
71
 
ETA receptors are located in the smooth muscle tissue of blood vessels, and binding of 
endothelin to ETA increases vasoconstriction leading to an increase in blood pressure.
4,69,71
  
ETB receptors are primarily found on the endothelial cells lining the interior of the blood vessels. 
NO is released when endothelin binds to these receptors.
4,69,71
  
Both ETA and ETB receptors are present in the nervous system where they may play a role in the 
mediation of neurotransmission and vascular functions.
72
 
1.7 Oxygen Saturation 
Healthy blood circulation provides tissues with a vital amount of oxygen required for cell 
function. Oxygen in the blood stream is transported by hemoglobin contained in a red blood 
cell.
5,73,74
 A hemoglobin molecule consists of four units, and each unit has a heme that can be 
bound to oxygen.
5
 Hemoglobin is bound to oxygen in high oxygen partial pressure, while it 
releases oxygen in low oxygen partial pressure.
73,74
 The content of hemoglobin that binds to 
oxygen is represented as the degree of the oxygen saturation (SO2); 100% oxygen saturation 
represents that all hemoglobin molecules bind to the maximum oxygen.  
The study of oxygen transport through the circulation requires the assessment of hemodynamics 
and oxygenation of individual RBC‟s within microvessels. Since approximately 98% of oxygen 
carried by blood is bound to the red blood cells (RBC‟s)  (with the remaining 2% dissolved in the 
plasma), a relatively accurate estimate of the quantity of oxygen carried in the blood can be 
obtained from measurements of hemoglobin oxygen saturation.
73
  
Current applications of the measurement of oxygen saturation are based on many years of 
research. Measurements of oxygen consumption date as far back as 1932 and were recorded in 
the human hand, and in the ear of experimental animals.
75
 
Measurement of retinal blood oxygen saturation has been used to provide a microcirculatory 
assessment of the hemodynamic state of the retina.
58,76-80
 Common methods to measure oxygen 
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saturation in the retinal vessels are based on quantitating the differences between oxyhemoglobin 
and deoxyhemoglobin light absorption spectra at different wavelengths.
57,58,80
 
1.7.1 Lambert-Beer Law 
The Lambert-Beer Law is an empirical relationship that relates the absorption of light to the 
properties of the material through which the light is traveling. This law demonstrates that light 
transmission through a solution diminishes logarithmically as the concentration of the solution 
and the distance through it increases.
75
 
I = Io * 10
(-ε*d*C) 
where, I is the intensity of light transmitted through blood, Io is the original intensity of light, ε is 
a negative constant, d is the thickness and C is the concentration.
75
 
By rearranging the equation, it is evident that ε is proportional to log (Io/I). 
ε = (1/C * d)(log (Io/I)) 
where, ε is a specific extinction coefficient describing the portion of light that is lost due to 
absorption per unit distance and per unit concentration in a specific medium.
75
 
Since optical density is also defined by the same proportion (log (Io/I)), saturation is a function of 
optical densities and the properties of oxygenated and deoxygenated hemoglobin.
75
  
Simplified, oxygen saturation is equal to the percentage of oxygenated hemoglobin within total 
hemoglobin. However, we must take into account the extinction coefficients of the 
heterogeneous mixture of oxy- and deoxygenated hemoglobin. The specific extinction 
coefficients of oxy- and deoxygenated hemoglobin are detailed elsewhere.
81
 Using two different 
wavelengths, one that is isosbestic (the extinction coefficients for oxy- and deoxygenated 
hemoglobin are identical) and one that is oxygen sensitive, allows for the determination of 
oxygen saturation.
38,75,81
 Taking these principles into account, the relationship between oxygen 





1.7.2 Optical Density Measurements 
The principle of using the relationship between oxygen saturation and the ratio of optical 
densities has only been applied to the retina. Images of the eye are obtained with two 
wavelengths (oxygen sensitive and isosbestic).  Various groups have used different oxygen 









. From these images, the apparent OD can be calculated on 
desired vessel segments by obtaining the minimum intensity value inside the vessel and the 
average intensity outside the vessel.
58,73,80-82
 The optical density ratio (ODR) for a segment of a 
particular vessel is calculated by the following series of previously derived equations (using 
600nm/570nm as the two wavelengths)
58,80
: 
     
ODR = OD600/OD570 
OD600 = log10 [(Iout)/(Iin)] 
Iout = 1/M Σ Iout  
and, Iin = 1/M Σ Iin where M is the number of points (from 1 to M) 
OD570 = log10 [(Iout)/(Iin)] 
Iout = 1/M Σ Iout  
and, Iin = 1/M Σ Iin where M is the number of points (from 1 to M) 
 
1.7.3 Oxygen Saturation Calculation 








1.8 Oxygen Saturation Measurement Techniques in the Eye 
The methods used to estimate hemoglobin oxygen saturation are based on the assumptions about 
the relationship between light transmittance and oxygen saturation.
57,58,73,80
  
1.8.1 Reflectance Pulse Oximetry 
Pulse oximetry has become one of the most commonly used tools in the clinical setting for 
assessing patients' blood oxygenation status. It is a simple, non-invasive tool that measures the 
percentage of haemoglobin in the blood that is saturated with oxygen by using a probe to 
transmit light through the tip of a finger or the ear lobe. Most pulse oximeters typically have a 
pair of small light-emitting diodes (LEDs) facing a photodiode through a translucent part of the 
patient's body, usually a fingertip or an earlobe.
83,84
 One LED is red, with wavelength of 660 nm, 
and the other is infrared, 905, 910, or 940 nm.
83,84
 Absorption at these wavelengths differs 
significantly between oxyhemoglobin and its deoxygenated form, therefore from the ratio of the 
absorption of the red and infrared light the oxy/deoxyhemoglobin ratio can be calculated.
83,84
 The 
absorbance of oxyhemoglobin and deoxyhemoglobin is the same (isosbestic point) for the 
wavelengths of 590 and 805 nm.
83,84
 
A blood-oxygen monitor displays the percentage of arterial hemoglobin in the oxyhemoglobin 
configuration. Acceptable normal saturation ranges are from 95 to 100 percent, although values 
down to 90% are common.
83,84
  
1.8.2 Wavelength Comparisons 
1.8.2.1 Photographic Systems 
Retinal oximetry was initiated when a study that digitized fundus photographs taken with two 
illuminating wavelengths was published.
85
 This study estimated relative retinal vessel oxygen 
saturation by using ratio analysis and recording the OD at oxygen-sensitive and insensitive 
wavelengths.
85
 Because there are many factors that influence the relationship between oxygen 
saturation and retinal vessel reflectance and therefore vary across individuals, this approach 
requires calibration for absolute units of oxygen saturation. This method was extended by Laing 
et al
78
 and showed that oxygen saturation was linearly related with the ratio over physiological 
and hypoxic ranges of saturation.
82





and allowed them the ability to calculate absolute oxygen saturation values in single vessel 
segments. Reflectance spectroscopy is a popular method for saturation measurement and has 




 and four wavelengths.
88
  
1.8.2.2 Digital Systems 
Further advancements to these wavelength methods include the development of digital imaging 
systems.
79,80
 With these systems, the oxygen-sensitive and insensitive images are obtained and 
then analyzed by computers that use equations similar to those described in section 1.8.2 and 
1.8.3.  
1.8.3 Imaging Spectrometry 
Imaging spectroscopy uses light spectra reflected from and transmitted through a blood column 
and separately applies those reflected spectra to algorithms to calculate oxygen saturation.
89-92
 
The internally reflected spectrum is dependent on oxygen saturation and experimentally 
determined reflectance spectra of reduced and saturation whole blood.
89
 The transmitted 
spectrum is dependent on the background reflectance, oxygen saturation and experimentally 
determined transmission spectra (determined by measuring saturated and reduced whole blood at 
different concentrations and thicknesses).
89
 At wavelengths between 510nm and 586nm, only 
transmitted light is affected by tissue layer thickness and hematocrit (the proportion of blood 
volume occupied by red blood cells).
89-91,93
 Any effects of tissue layer thickness and hematocrit 




A system developed by Schweitzer
92
 obtains reflectance spectra of single fields from a line of 
tissue. A logarithmic scale is then used to plot the intensity of light reflected at each wavelength 
from the tissue sample. Once image quality is established,
94
 the system is designed to optimize 
the values of many unknowns, such as oxygen saturation.
91
  
1.8.4  Multi-Spectral Confocal Scanning Laser Ophthalmoscope 
A scanning laser ophthalmoscope acquires images at four wavelengths across a single video 
frame. There are three diode laser modules (635, 670 and 830nm) and one argon laser (488nm) 
that are made coaxial by a set of mirrors. The light is detected by a photodiode detector. 
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Transmittance through a vessel is calculated by using the image intensity from the background 
tissue. Irradiance from the background tissue is determined from points surrounding the vessel of 
interest and from computer software that estimates the background in absence of the vessel. If a 
central vessel reflex is present, a polarizer is used to decrease it, if there is no reflex present then 
the lowest image intensity value within the vessel is used.
95,96
 The ratio between the intensities of 




1.9 Conjunctival Hyperemia 
Ocular hyperemia is commonly known as “red eye” and is defined by the dilation of blood 
vessels on the anterior portion of the eye, giving rise to a reddish appearance
99
. Red eye is an 
attribute that has been of some considerable importance to patients and practitioners, since it is 
complicated and not well understood.  
The conjunctiva is a transparent, vascular mucous membrane that surrounds the anterior portion 
of the globe, not including the cornea. The conjunctiva is attached to the episclera, the anterior 
portion of the sclera.
100
 
Conjunctival hyperemia can be classified anatomically. The various locations of conjunctival 
hyperemia are bulbar, limbal and palpebral. The underlying initiators for hyperemia are different 





, the presence of foreign bodies, abrasions, fatigue, disease
106
, 





, an unstable tear film
109
 and dry eye. Each initiator may result in different reactions, 
ranging from quite mild to severe
110
. 
1.10 Grading of Hyperemia 
In research and in the clinic, ocular redness has been evaluated by means of subjective grading 
since it is simple to do and non-invasive. However, it is important that the grading system that is 




1.10.1 Subjective Grading 
There are many types of subjective grading systems that are used, but there is not one that is 
standard.
111
 Some subjective systems require the clinician to use a biomicroscope to examine, 
judge and compare the redness based on a scale or a series of pictures.
112,113
 Some of the 
subjective methods include questionnaires, numeric scales and descriptive scales, but they tend 
to have less sensitivity when it comes to detecting meaningful change.
114
  
Even though the use of scales tends to be less time consuming and inexpensive, these have a 
decreased reliability due to the intra- and inter-observer inconsistencies.
115,116 
Some methods use 
redness grading scales based on a 4 point scale, 1 being mild. So, a 1 on the scale to one observer 
may be a 1.5 or 1.75 on the scale to another observer.  
There are other redness measurement methods that segment the eye into different quadrants and 
are based on the number of blood vessels within those quadrants.
117
  
Although the numeric scales use a global language (numbers) and are more readily used than 
descriptive scales and questionnaires, they are still regarded as having a lower sensitivity when it 
comes to detecting meaningful change.
114
 A more objective method of measurement would be 
advantageous. 
1.10.2 Objective Redness Measurement 
Other methods of redness measurement are based on objective means with the expectation of 
being more reliable.
118
 Unfortunately these methods are sometimes more expensive and time 
consuming and can be regarded as less clinically-friendly. 
Some of the examples of objective measurement methods used include: Photographic imaging 










One method in particular involved automated measurement of scales and image analysis.
120
 This 
study developed an automated method of redness measurement by comparing redness and blood 
vessel appearance from several images to the redness values assigned by clinicians, on a 100-
point scale, in a web survey.  
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1.10.3 Colour Science and Colourimetry 
There are 3 attributes that can be used to describe a colour; saturation, hue and, luminance.
124,125
 
Saturation is best described in terms of the amount of white present in a colour. The more of 
white present in a colour, the less saturated the colour. The absence of white in a colour is a 
completely saturated colour. The second component is hue. The colour itself, for example red, is 
the hue. So if pink is a mixture of red and white, then pink and red have the same hue, but 
different saturations. The third component is luminance, the measure of brightness.
124,125
  
1.10.4 The Chromaticity System  
There are various colour systems that have been used to measure the luminance, hue and 
saturation of colour.
124,126
 The system of interest is objective and is called the CIE system (The 
Commission Internationale de L‟Éclairage).
127
  
The CIE system is a measurement system for colour and is represented in a chromaticity 
diagram.
124-126
 The system is based on the spectral power distribution parameters (SPD). The 
SPD is a classification of the power of light at each specific wavelength viewed by the eye.
124-126
 
Once the data about light are known, then colour can be analysed quantitatively. SPD can be 








The colour system in which part of the upcoming experiments are based on, is the CIE L‟ u‟ v‟ 
colour space diagram.
124-126
 The variable u‟ has been used to represent and measure ocular 





1.11 Ocular Pharmacology and Therapeutics 
Irritants cause vasodilation, redness and oedema in the eyelid margins, palpebral, orbital and 
bulbar conjunctiva.
121,129
 One of the responses of the vasculature to irritation is the dilation of 
blood vessels.
121,129,130
 The primary vasodilatory substances are those responsible for acute 
conditions associated with external irritants and allergens (e.g. histamine) and those that are 
biological mediators (e.g. prostaglandins), involved in a more chronic vasodilatory and 
inflammatory response.
131
 The histamine and prostaglandin-mediated systems can be 




1.11.1 Anti-Allergy and Decongestant Agents 
Histamine, prostaglandins, leukotrienes and various cytokines get released from mast cells 




1.11.1.1 Type I Hypersensitivity Reactions 
Type I reactions are anaphylactic and Immunoglobulin E-mediated (IgE).
132,133
 These reactions 
occur when an antigen (e.g. pollen, drug) is re-introduced to someone who has previously been 
exposed to it.
133
 The initial exposure causes the production and attachment of IgE antibodies to 
mast cells after which, a re-introduction to that specific antigen causes their degranulation.
132
  
The disruption and degranulation of mast cells cause the release of large quantities of 
inflammatory mediators (e.g. histamine, prostaglandins, leukotrienes etc.).
133
 Histamine activates 
the H1 receptors on the blood vessels causing vasodilation.
132
 When vessels dilate, they become 
leaky and fluid escapes causing swelling.
132
 
The ocular diseases that are manifested by type I reactions include seasonal allergic 






1.11.2 Ocular Drug Entry 
The pharmacokinetics of a drug determines the rate at which the drug is absorbed by the 
system.
137
 Drugs affecting blood vessels alter the existing cell function by among other things 
either mimicking a neurotransmitter (e.g. phenylephrine binds to an α-adrenergic site) or 
blocking the action of a neurotransmitter.
132,138
 Drugs will bind to specific sites or receptors such 
as proteins on a cell surface, active sites on enzymes or within cells. Drug binding and action 




There are a few ways in which an ocular drug can enter the eye. One way is through the cornea 
to the aqueous humour.
132,133
 Only lipid-soluble drugs are able to pass through the tissue, but 
since the stroma is made up largely of water, the molecule entering must be bi-phasic.
132,138
 A 
second way that drugs can enter the eye is through the systemic circulation via the conjunctival 
and lid vasculature or the nasolacrimal drainage system.
132,133
 If absorption takes place, the drug 
enters the blood stream, but is eliminated systemically.
132,138
 Because of systemic absorption, the 
ocular effect could be lessened. Drainage in the nasolacrimal system usually includes absorption 
of some of the drug into the blood from the vascularised lining of the nasolacrimal duct.
132,138
 
This occurrence could account for systemic toxicity.
132
 
Topical ophthalmic pharmaceuticals are mainly water soluble formulations and are miscible with 
the aqueous phase of the tear film and penetrate into the eye.
132,138
 The properties of the drug in 
water determine its corneal penetration, with the net ionic charge on the drug being the most 
important determinant.
132,133
 The pH and the time the drug is in contact with the ocular surface 
are also factors that determine the permeability of the drug and ultimately its penetration.
132,138
 
The conjunctival tissue contains numerous secretory cells and glands that could have a 
substantial impact on the net absorption of a drug and therefore, drug penetration into the 
conjunctival tissue is twice as high as it is in the cornea.
132,138
 
Topical ocular drugs are absorbed via the conjunctiva or cornea and enter the anterior ocular 
tissue and aqueous humor. The effects of the drug are anterior and do not move more posterior 
than the crystalline lens.
132
 The ultimate removal of the drug is achieved via the uveo-scleral 





1.11.3 Countering vasodilation 
Histamine and prostaglandin-mediated systems can be manipulated with topical pharmaceuticals 




Decongestants can manage exposure to dry or dusty work places, exposure to chemicals and 
fumes and strain from dry environments.
132
 Over use of decongestants can cause a rebound effect 
and can reduce ocular sensitivity to allergens and irritants.
139
 
Decongestant activity has a direct α-adrenergic action or histamine H1-blocking action on the 
superficial conjunctival vasculature.
132,138
 Adrenergics will stop vasodilation and/or cause 
vasoconstriction of the vessels and mydriasis by interacting with the α1-receptors on the blood 
vessels.
132,138
 Drug interaction with the receptors will help counter vasodilation and other signs 
and symptoms of a mild inflammatory condition.   
The vasoconstricting effect of these adrenergic agonists makes them useful topical 
decongestants.
132,138
 Some common decongestants include phenylephrine and imidazole 
compounds.  
Phenylephrine is an α-adrenergic receptor agonist used primarily as a decongestant, as an agent 
to dilate the pupil and to increase blood pressure.
139
 It is useful since it is quite effective at low 
concentrations while causing little to no pupil dilation. 
Imidazole compounds such as, naphazoline, tetrahydrozoline and oxymetazoline are also 
sympathomimetic agents with α-adrenergic activity.
138
 They can act as vasoconstrictors with a 
rapid action in reducing swelling when applied to mucous membranes. They act on α-receptors 




1.11.3.2 Antihistamines, mast cell stabilizers 
Many people suffer from allergies. These are caused by an excessive response of the body to 
allergens such as the pollen released by grasses and trees. An allergic reaction indicates an 
excessive release, by the body, of histamines.
132,138
 Antihistamines are used for the reduction of 





Several H1-receptor antagonists are formulated for topical, ocular use. Ophthalmic antihistamines 
have dual action: 1) to block histamine from the H1 receptors and; 2) prevent the release of other 
mediators from cells involved in allergic reactions (e.g. mast cells which are found in several 
types of tissues and contain many granules rich in histamine).
138
  
There are many compounds used for antihistamine action including, azelastine hydrochloride, 
cromolyn sodium, epinastine hydrochloride and diphenhydramine.
132
 
1.11.3.3 Corticosteroids and Non-steroidal anti-inflammatory drugs (NSAIDs) 
Synthetic topical drugs with corticosteroid-like effect are used in a variety of conditions and can 
be used in the treatment of various inflammatory conditions (hyperemia, cellular infiltration, 
vascularisation).
131
 Corticosteroids can be warranted if rapid relief is needed to control non-
specific inflammatory and immunologic diseases of the eye.
132
 
The corticosteroidal benefits on ocular inflammation are: a decrease in capillary permeability and 
cellular exudation, an inhibition of mast cell degranulation, a suppression of lymphocyte 
proliferation, an inhibition of phospholipase-A synthesis (resulting in a decreased synthesis of 
prostaglandins and leukotrienes) and an inhibition of a cellular-mediated immune responses.
131
 
NSAIDs are “aspirin-like”/salicylate drugs with analgesic, antipyretic and, in higher doses, anti-
inflammatory effects.
131
 The term "non-steroidal" is used to distinguish these drugs from 




Most NSAIDs act as non-selective inhibitors of the enzyme cyclooxygenase, inhibiting both the 
cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) isoenzymes.
131
 Cyclooxygenase is 
essential in the formation of prostaglandins and thromboxanes from arachidonic acid.
138
 
Prostaglandins act (in addition to other things) as mediators in the process of inflammation. In 
the eye, prostaglandins mediate inflammation by disrupting the blood-aqueous humor barrier 
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Our ability to assess ocular circulation has evolved over many decades from a subjective 
physical description of the visible vessels to direct and indirect quantitative measurement of a 
number of ocular hemodynamic parameters. Today, the techniques available for hemodynamic 
assessment each examine a unique facet of the ocular circulation. These methods have the 
potential to contribute greatly to our understanding of normal hemodynamics with the goal of 
adding to our understanding of altered hemodynamic states, such as those found in disease. Each 
ocular hemodynamic technique provides contributions to the understanding of ocular physiology 
with the potential to provide signs for diagnosis and treatment. 
By measuring red blood cell velocity, oxygen saturation and ocular surface redness in the 
conjunctival vessels we are able to study the changes that occur in the circulation and the levels 
of oxygen delivery and saturation over many states and conditions. By establishing baseline 
levels of these measurements with healthy individuals, it will give us a basis of comparison to 
situations which affect this baseline. 
A major objective of this work was to design a system that could track individual red blood cells 
as they travel through capillaries, thereby allowing analysis of hemodynamic and oxygenation 
parameters of individual cells over time and position. A high magnification camera was used to 
capture videos that would allow for the assessment of ocular capillary hemodynamics. In 
addition, videos were taken with specific single wavelength interference filters to allow for the 
calculation and assessment of oxygen saturation values. Method validation was achieved through 
simulation videos and a unique isocapnic hyperoxic stimulus. By using the combination of these 
two techniques, we can provoke changes in ocular hemodynamics by using various stimuli in 
healthy groups of volunteers, to try to obtain a greater understanding of the physiology of blood 
flow and its regulation. 
The first aim of this thesis was to develop and validate a method capable of producing high 
magnification videos for accurate red blood cell velocity calculation. Once a camera capable of 
this task was decided upon, proper set up (camera and subject) and video acquisition techniques 
needed to be fine tuned in order to achieve videos with a sufficient amount of resolution for pre- 
and post-processing. The goal to estimate red blood cell velocity would ultimately be achieved 
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through the use of various processing techniques (pre-processing and registration, vessel tracking 
and velocity estimation). Validation of the estimation technique was accomplished using 
simulation videos with known velocities and comparing those velocities with the ones estimated 
by the algorithms (Chapter 3). An additional aim was to establish and validate a method to 
estimate hemoglobin oxygen saturation levels in the vessels on the anterior ocular surface 
(Chapter 4). Common methods to measure oxygen saturation in the retinal vessels are based on 
quantitating differences between oxyhemoglobin and deoxyhemoglobin light absorption spectra 
at different wavelengths. These principles were modified for assessments on the anterior ocular 
surface. The hypotheses of Chapter‟s 3 and 4 were that the hemodynamic and oxygen saturation 
measurement methods would accurately reflect real velocities and real changes in saturation as 
demonstrated by the validation techniques. 
Having developed the two methods that can accurately assess red blood cell velocity and oxygen 
saturation, the second aim of this thesis was to define the magnitude of change, if any, of 
conjunctival red blood cell velocity and oxygen saturation in a group of clinically normal 
subjects. Red blood cell velocity, oxygen saturation and ocular redness measurements were 
acquired every hour over the course of a day. The measurements acquired in these healthy 
individuals were used to facilitate our understanding of ocular hemodynamics (Chapter 5). In 
addition, these measures were compared in two age strata. The hypothesis was that there would 
be no change over time for all three measures in the group of healthy individuals. When 
comparing strata, it was expected that subjects in the older age stratum would have increased 
levels of redness, and decreased red blood cell velocities when compared to the younger age 
stratum. It was expected that the blood oxygen saturation levels in the older aged stratum would 
be lower than the younger aged stratum. 
The next aim of this thesis was to demonstrate the validity of the two established methods and at 
the same time, to examine the characteristics of the RBC velocity, oxygen saturation levels and 
ocular redness levels in clinically normal subjects when a topical vasoconstrictor was instilled 
onto the eye (Chapter 6). Measurements were acquired before and after the instillation of a 
vasoconstrictor. The change in red blood cell velocity, oxygen saturation and ocular surface 
redness was calculated and compared between all time points. The hypothesis was that the 
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vasoconstrictor would cause the red blood cell velocity and ocular surface redness to decrease 
while oxygen saturation remained stable.  
The fourth aim of this thesis was to evaluate the effect of conventional contact lens wear on red 
blood cell velocity, oxygen saturation and ocular surface redness in subjects with a history of 
contact lens wear compared to subjects that did not have a history of contact lens wear. With the 
advent of newer contact lens materials on the market, these techniques could possibly show 
whether ocular health, specifically corneal health, has improved with these new lenses of choice. 
Red blood cell velocity, oxygen saturation and ocular redness measurements were acquired every 
hour over the course of a day for both groups. The variations over time and between subject 
groups were characterized (Chapter 7). The hypothesis of this section was that the subjects who 
wore contact lenses on a regular basis would have a decreased red blood cell velocity, decreased 
oxygen saturation and an increased ocular surface redness when compared to the group of 















3. Validation of the estimation of average red blood cell velocity 
in conjunctival vessels using simulation videos 
3.1 Overview 
Purpose: Measurement of retinal blood flow has been used to provide a microcirculatory 
assessment of the hemodynamic state of the retina. To date, there have been no studies that have 
looked at measuring real-time blood velocity in bulbar conjunctival vessels. The objective was to 
design, develop and validate a system that would non-invasively quantify the red blood cell 
velocity in the conjunctival capillaries. A tool was developed to automatically analyze video 
sequences of conjunctival capillaries, digitally imaged with high enough magnification to resolve 
movement of the blood within the vessel, with the future prospect of gaining a comprehensive 
understanding of the conjunctival circulation in health and disease. Methods: Simulations 
representing moving RBCs within a vessel and the random variation of each cell in terms of 
speed, shape and intensity were created in order to evaluate the performance of the algorithm. 
Gaussian noise was added to simulate disturbances and random misalignment between frames. 
Videos were pre-processed and registered to improve image quality and then the algorithm was 
set up to automatically recognize the vessels within the sequences. For each vessel, a signal that 
correlated to blood cell position was extracted from each frame, and the inter-frame displacement 
was estimated through a modified dynamic time warping (DTW) algorithm. This provided the 
red blood cell velocity over time in each point of the vessels. Thus, from these estimates, the 
mean red blood cell velocity for each vessel was easily evaluated. The true mean velocity from 
the simulation with the one estimated by the algorithm was compared and the system accuracy 
was determined. Results:  Results for the simulated videos demonstrate a very good concordance 
between the estimated and actual velocities. The mean relative error for the modified DTW 
method is 6%. Conclusions: Signal displacement estimation through DTW algorithm can be 
used to estimate mean red blood cell velocity. Successful application of the algorithm in the 
estimation of RBC velocity in conjunctival vessels was demonstrated. Signal displacement 
estimation demonstrated very good concordance to the actual velocities supporting its validity. 
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This technique promises to enable the study of conjunctival hemodynamics under various 
experimental and physiological conditions. 
3.2 Introduction 
The eye is a unique structure because it is one of the few locations in the body where we can 
non-invasively monitor capillary blood flow. This advantage provides a unique opportunity to 
study hemodynamics. What is also advantageous is that the reactivity of the vessel walls in the 
bulbar conjunctiva are similar to the reactivity of the vessels in connective tissue elsewhere in 
the body (unlike the skin).
1
 There is a lack of information regarding the anterior surface and its 
hemodynamics in healthy people. This lack is in part due to the unavailability of real-time 
research tools and methods to non-invasively quantify micro vascular parameters (in health and 
disease). 
There are many factors that are responsible for the regulation and control of ocular blood flow 
(e.g. metabolic demands, ocular perfusion pressure etc.) and the examination of the interactions 
of these factors, alone and in concert, will give us insight into the potential hemodynamic 
alterations that occur during disease or various altered states.
2
 
The measurement of retinal blood flow provides a microcirculatory assessment of the 
hemodynamic state of the retina and studies of this nature are much more common in the 
literature.
3-12
 There are publications that deal with various aspects of quantitatively and 
qualitatively measuring the blood flow of the posterior eye. There are techniques
10,11,13-20
 
available for these tasks, and there is usually more than one method used at one time to aid in the 
complete understanding of ocular hemodynamics. These methods, detailed in Chapter 1, are used 
to visualize and measure directly or calculate indirectly a variety of aspects related to ocular 
blood flow.  
In the retina, the estimation of the velocity of red blood cells (RBCs) from in vivo microscopy 
videos is generally divided into two categories. One category is where the vessel calibre is large 
enough so that the blood cells are able to move within the vessel both along its axis and in its 
perpendicular direction (large artery hemodynamics).
21
 This situation demands precise tracking 
of each RBC movement in order to estimate both components of the movement.
22
 The second 
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category involves small calibre micro vessels.  Since the calibre of these vessels is relatively 
small (5-10 µm), red blood cells, which are a mere 6-8 µm in diameter,
23
  are only capable of 
lining up and moving along the vessel in a single-file. The estimation of RBC velocity and 
movement through a capillary network is achieved through the image analysis of video 
recordings. Several techniques currently exist for measuring various parameters in the retina (e.g. 






To date, there have been no studies that have looked at measuring real-time blood velocity in 
bulbar conjunctival vessels. It has been suggested that the appearance of blood that flows 
through the arterioles on the surface of the human body is the same as that which flows through 
the arterioles in the brain, lung, intestines, skeletal muscle, kidney, ureter and bladder.
1
 The 
blood that flows through the capillaries of the bulbar conjunctiva is a valid sample and 
comparable to that of the composition of the blood in all of the capillaries in the body.
1,2
 
There are many advantages of in vivo observations of red blood cell hemodynamics in the bulbar 
conjunctiva. These advantages include that there is no treatment or preparation required for the 
surface of the eye in order to study the moving particles, the possibility of adequate optical 
resolution of the flowing blood, maximum contrast between the red blood and the white sclera 
and the tissue under investigation is bathed by its own isotonic fluid (tears). The development of 
newer techniques and their correct use, combined with a careful analysis and consideration of the 
results provides the potential for assessing ocular blood flow in humans. 
In biomicroscopy videos that are taken in a clinical setting, the cells within the capillaries are 
barely recognizable (low magnification and resolution), and this makes the task of accurate 
tracking quite difficult. Using a camera that offers high enough magnification to clearly resolve 
movement of the blood within the vessel with good resolution, the task of estimating RBC 
velocity at specific points and across vessels over time becomes less intimidating. By coupling 
good quality videos with specifically designed algorithms to automatically estimate RBC 
velocity profiles, we are able to measure a detail of the circulation. 
Therefore the purpose of this study was to design, develop and validate a system that would non-
invasively quantify the red blood cell velocity in the conjunctival vessels and could meaningfully 
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be interpreted by way of a standardized model. A tool that was previously developed was used to 
automatically analyze video sequences of conjunctival vessels, digitally imaged with high 
enough magnification to resolve movement of the blood within the vessel, with the future 
prospect of gaining a comprehensive understanding of the conjunctival circulation in health and 
disease. 
3.3 Materials and Methods 
3.3.1 Simulated Vessels 
In order to evaluate the performance of the algorithm, a simulation representing moving RBCs 
within a vessel was created. After drawing an arbitrary line representing the vessel center line, 
the line was populated by circles representing a Gaussian intensity pattern. Their diameters and 
mean intensity were drawn from normal distributions. The video was generated by moving each 
cell separately along the vessel center line with a speed chosen (for each frame and for each cell) 
from a normal distribution. When a particular cell would fall out of the end of the vessel it was 
eliminated from the video and similarly, when there was a place for a cell at the beginning of the 
vessel, a new one was inserted. The image background had a constant intensity with the addition 
of noise, with a standard deviation proportional to the image intensity. An example of a 












3.3.1.1 Pre Processing 
Image sequences were converted to AVI files so that the algorithm was able to analyze them. 
Automatic analysis of the simulated conjunctival videos required that the information carried by 
each pixel was kept consistent throughout the entire sequence (i.e. if a pixel represented a point 
of a particular vessel, it had to do so in every frame of the video). In addition, imaged intensities 
of similar objects (RBC) in similar positions were required to be as comparable as possible.  
A few issues with the videos that had to be resolved were the illumination and small movements. 
Movements cause subsequent frames in the sequence to be misaligned. Due to these movement 
effects, the same position within a vessel had the possibility of being imaged in different 
positions in different frames. The uneven illumination made the same red blood cell appear quite 
different. Given a video composed of several frames, the illumination showed a distinctive 
pattern (highest in the center of the frame and decreased smoothly toward the borders, with a 
central symmetry). Assuming that each frame was considered an independent entity, the 
luminance pattern for each frame was estimated separately, as well as for each pixel of 
coordinates, in order to remove the uneven pattern. After correcting the illumination, the 
geometric transformation among frames was corrected. It was assumed that the misalignment of 
the frames was due to translations and therefore, the estimation of the horizontal and vertical 
shift between two frames was estimated as the peak of their phase correlation.  
Once pre-processing of the videos was complete, the algorithm then had to indentify the vessel 
structures. The different segments of vessels were automatically extracted from the video image 
by taking the mean of all the registered frames. A previously developed algorithm
31
 was used for 
vessel recognition and is described in full elsewhere.
32
 After vessel structure recognition the 
algorithm was able to estimate RBC velocity. 
 
3.3.1.2 Velocity Estimation 
The goal of velocity estimation was to treat the grey level intensity of each vessel as a signal, and 
not to track the single red cells (Figure 3-2). For each vessel, a signal that correlated to blood cell 
position was extracted from each frame, and the inter-frame displacement was estimated through 
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a modified DTW (dynamic time warping) algorithm that was able to calculate a point-wise 
estimation of velocity. 
 
Figure 3-2: Example of gray level intensity extraction of a vessel segment 
 
The grey level values were considered on a vessel axis and it was assumed that the valleys in the 
intensities corresponded to the presence of RBCs, whereas the high intensities corresponded to 
the plasma. The average displacement of RBC between two frames of a video was then estimated 
by the shift of two, on-axis, grey level signals. This estimation is sometimes achieved by using a 
simple correlation algorithm, but due to the different velocities and intensities of each cell among 
the different frames, the signals were warped and unmanageable.
31-34
   In order to deal with these 
irregular cell dynamics in the capillary vessels, a modification of an algorithm used in the speech 
recognition community, dynamic time warping, was used.
33,34
 The intention was to estimate the 
local displacement of two signals and therefore, the only assumption made was that no RBC 
suddenly appeared or disappeared within a vessel. 
Dynamic time warping (DTW) tries to evaluate the local translation of two signals (warping).
32
 
This is particularly useful in dealing with objects that can distort their shape or vary their relative 
distances like red blood cells. In order to estimate the velocity of the RBCs it was necessary to 
evaluate the translations they undergo between subsequent frames. Different frames showed the 
same sequence of cells, but displaced along vessels. The signals extracted appeared as time-
shifted versions of one another (i.e. the higher the velocity, the larger the shift). Therefore, 
velocity estimation became a problem of phase displacement estimation (Figure 3-3). The DTW 
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algorithm found the path that minimized the distance between the grey-level intensities of two 







































Figure 3-4: The connection of two pixel-point signals using the DTW algorithm 
 
There were other conditions that the algorithm verifies
34,35
 as well as the addition of a memory 




An attractive advantage of the DDTW is that it can give an estimation of the mean velocity for 
the entire vessel, the instantaneous velocity for the entire vessel and the instantaneous local 
velocity. This advantage gives us the opportunity to study the variation in the velocity both along 
the vessel and in time. Using a graticule for calibration (Figure 3-5), the red blood velocity was 









It was calculated that 1mm measured on the graticule corresponded to 660 pixels and therefore, 1 
micron corresponded to 1.5 pixels. Having a frame rate of 7 frames per second resulted in a 
calibration factor of 10.71. The calibration factor was applied to initial results in frames/second 
to achieve meaningful units of microns/second. 
3.4 Results 
Results for the simulated videos consisting of the mean of 10 different simulated videos for each 
velocity are shown in Fig. 3-6, demonstrating a very good concordance between the estimated 
and actual velocities. The variance of the estimates is so small that it is not visible in the plot, 
and is smaller than the dimension of the plot marker. The mean relative error for the modified 
DTW method is 6%.  
 





A novel method for tracking RBCs and estimating RBC velocity in conjunctival vessels has been 
established. By using a DTW algorithm and a simulation video displaying a vessel with RBC 
movement, the estimation of RBC velocity is possible. One goal of this study was to assess the 
validity of the DTW method. By estimating velocity within a simulated vessel and comparing 
those values to the actual velocities this goal was achieved.  
Current literature regarding ocular circulation measurements pertains to the retina. 
3-12
 To our 
knowledge this chapter introduces the only direct method available using image processing that 
is capable of non-invasive red blood cell velocity measurement in conjunctival vessels. 
Literature involving conjunctival vessel changes or responses relate to morphometry.
2,36
 Devices 
and techniques used for circulation measurements in the retina have several disadvantages 
including the lack of meaningful units, indirect methods, high expense and requirement of skilled 




This chapter demonstrated the validity of the DTW algorithm by using a simulated vessel with a 
series of velocities. The low variance of the estimates and low mean relative error demonstrate 
the accuracy of this technique. This validation technique would be a valuable tool to demonstrate 
the accuracy in future methods and cross-functionally. 
3.6 Conclusion 
Signal displacement estimation through DTW algorithm can be used to estimate mean red blood 
cell velocity. Successful application of the algorithm in the estimation of RBC velocity in 
conjunctival vessels was demonstrated. Signal displacement estimation demonstrated very good 
concordance to the actual velocities supporting its validity. This technique promises to enable the 
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4. Measurement of oxygen saturation in conjunctival vessels  
4.1 Overview 
Purpose: Measurement of retinal oxygenation saturation has been used to provide vital clinical 
information about the metabolic state of the retina. To date, there have been no non- invasive 
studies that have looked at the oxygen saturation in bulbar conjunctival vessels. The objective 
was to: a) design and develop a method in order to non-invasively quantify the changes in blood 
oxygen saturation (SO2) in the conjunctival vessels and demonstrate reliability of the measures 
and, b) demonstrate the application of the method by showing a response to an isocapnic 
hyperoxic provocation and compare those values to the results from an instrument. Methods: a) 
The sample consisted of 6 males and 6 females of average age 27.1 (range 19-34 years). 
Conjunctival vessels were imaged with dual wavelengths using a Zeiss slit lamp at 32x 
magnification. Images were obtained through narrow band interference filters with O2-sensitive 
and O2-insensitive peak transmissions (440nm and 570nm, respectively). Images were imported 
into the image processing application ImageJ and optical densities (OD) were calculated from 
vascular segments using the average reflected intensities inside and outside the vessels. Optical 
density ratios (OD440/OD570) were used to calculate relative oxygen saturation values. Video 
images of the bulbar conjunctiva were recorded at three times of the day. Three different areas of 
one vessel were analyzed using the dual wavelength method for each subject at each time point. 
The same area was also measured using this method for five consecutive frames. Measurement 
repeatability was assessed over location at each time and across consecutive frames. b) The 
sample consisted of 5 subjects (mean age 29.6; range 24-34 years). Subjects initially breathed air 
for 10 minutes followed by pure oxygen (O2) for 20 minutes, and then air for a final 10 minute 
period using a sequential re-breathing circuit (Hi-OxSR, Viasys). Simultaneously, SO2 values 
measured with a pulse oximeter ear clip and finger clip were recorded. The validity of the dual 
wavelength method was demonstrated by comparing the values to those from the ear clip pulse 
oximeter. Results: The intraclass correlations (ICCs) between the three locations at each time 
point were 0.93, 0.56 and 0.86 respectively. Measurements across 5 consecutive frames showed 
no significant difference for all subjects (p=0.60; ICC = 0.96). The ICCs between the two 
methods at each time point were 0.45, 0.10 and 0.11 respectively. a) There was no significant 
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difference in SO2 between the three locations measured using the dual wavelength method for all 
subjects (p=0.31). There was also no significant difference between the three locations at any of 
the time points for the dual wavelength method (p=0.37). b) In response to isocapnic hyperoxic 
provocation using the dual wavelength method, blood oxygen saturation was increased from 
control values (mean ± SD) of 94.0 ± 1.5% to 96.7 ± 1.3% (p=0.04) and subsequently recovered 
after withdrawal of hyperoxia to 94.8 ± 0.7% (p=0.03). Blood oxygen saturation values recorded 
from the ear clip and finger clip of the pulse oximeter also showed an increase from control 
values of 95.5 ± 1.1% to 98.3 ± 1.1% (p<0.01) and 97.3 ± 1.1% to 98.8 ± 0.5% (p=0.02) and 
subsequently recovered after withdrawal of hyperoxia to 96.3 ± 1.3% (p<0.00) and 97.3 ± 1.1% 
(p=0.01) respectively. SO2 comparison between the dual wavelength method and the ear-clip 
pulse oximeter method did not show a significant difference (p=0.54). The interaction between 
the two methods and time on SO2 was not significant (p=0.18). Conclusions: The application of 
the dual wavelength method was demonstrated and optical density ratios can be used in a reliable 
manner for relative oxygen saturation measurements. This valid method promises to enable the 
study of conjunctival O2 saturation under various experimental and physiological conditions.  
4.2 Introduction 
Healthy blood circulation provides tissues with a vital amount of oxygen required for cell 
function.
1
 Oxygen in the blood stream is transported by hemoglobin in the red blood cells. A 
hemoglobin molecule consists of four units, and each unit has a heme that can be bound to 
oxygen. Hemoglobin is bound to oxygen in high oxygen partial pressure, while it releases 
oxygen in low oxygen partial pressure.
1
 The content of hemoglobin that binds to oxygen is 
represented as the degree of the oxygen saturation. 
Pulse oximetry has become one of the most commonly used tools in the clinical setting for 
assessing patients' blood oxygenation status.
2-5
 It is a simple, non-invasive tool that measures the 
percentage of haemoglobin in the blood that is saturated with oxygen by using a probe to 
transmit light through the tip of a finger or the ear lobe. Most pulse oximeters that are commonly 
used in medical practice utilize the difference of oxy- and deoxyhemoglobin absorptions at two 
wavelengths; red and near-infrared. Pulse oximetry is a well recognized and commonly used 
method of measuring blood oxygen saturation and therefore, it is usually preferred over invasive 
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measurements from arterial lines.
6
 It is important that the monitors used to make these 
measurements produce accurate, responsive and reliable results. A study has shown that the use 
of finger probes results in output delays of up to approximately 15 seconds when compared to 
readings taken with an ear-clip probe.
5
 When rapid changes in SO2 are expected, it is preferable 
to use an ear lobe probe when using pulse oximetry.
5
 
Retinal blood oxygen saturation has previously been used to demonstrate the metabolic state of 
the retina.
2,7-14
 Reflectance spectroscopy dates back to the late 60s
15,16
 and is a common method 
that can measure oxygen saturation in the retinal vessels. This method is based on quantitating 
the differences between oxyhemoglobin and deoxyhemoglobin light absorption spectra at 
different wavelengths.
2,7
 Much progress has been made since then to improve the approach.
11-
13,17-19
 One of the drawbacks of this technique is the restriction on the number and locality of 
measurements at one single cross section of one or two vessels. In more recent literature newer 




SO2 can be manually calculated since there is a linear dependence of the SO2 in a (retinal) vessel 
to the ratio of the logarithmic contrast of the vessel versus its surrounding at two specific 
wavelengths, the optical density ratio (ODR).
8-10,22
 Using this relationship, the SO2 can be 
calculated from two images at two wavelengths. Recently, an automated method that is based on 
the above principle and uses an image splitter was developed for use on the retina. 
12
 
Retinal vascular reactivity studies reported in the literature have typically used gas delivery 
systems to induce a change in vascular parameters. These systems usually utilize a reservoir bag 
and one-way valves to essentially counteract the mixing of inspired and expired gases (a non-re-
breathing system). Since hyperoxia naturally stimulates hyperventilation (faster or deeper 
respiration), an uncontrolled and unpredictable reduction of the partial pressure of arterial carbon 
dioxide (PCO2) occurs.
23,24
 A reduction in the PCO2 tends to exaggerate a vasoconstrictive 
consequence. Therefore a vasoconstrictive effect that may otherwise be attributed to hyperoxia 
when using non-rebreathing circuits can most likely represent a combined effect of increased 
PO2 and decreased PCO2 levels.
25
 Previous studies have acknowledged this probable exaggerated 
effect and have experimented in many ways in the attempt to correct for it.
1,26-29
 A useful system 
 
62 
that maintains a constant PCO2 level (isocapnia) uses a sequential re-breathing circuit that has a 
feedback loop in order to balance a reduction in PCO2 caused by hyperventilation.
25,30
  
The information regarding the anterior surface of the eye and its hemodynamics in healthy 
people is limited. One study looked at the microvascular abnormalities in the conjunctival 
circulation of paediatric diabetic patients and revealed a significant change when compared to 
healthy patients.
31
 However, despite being aware of the significance of circulation in vivo we 
know little of the factors influencing this on the ocular surface in healthy people and 
consequently in those with vascular anomalies.  
The quest to connect intellectual ideas with scientific facts is often pursued by researchers and 
clinicians. Validity is the degree to which a study accurately assesses the specific idea a 
researcher attempts to measure.
32,33
 The concept of validity is often discussed in connection with 
measurement reliability. However, a reliable measure is not necessarily valid. That is, a reliable 
measure can measure something consistently, but not necessarily what it is supposed to measure. 
A measurement method is valid if it is measures or calculates actual, real values consistently.
32,33
  
In this study, we establish and validate a new, simple, filter-based method for bulbar conjunctival 
vessel oximetry. The reliability of the dual wavelength method was tested across digital video 
frames and between locations on a single vessel for a series of subjects. The application of the 
dual wavelength method was demonstrated using an isocapnic hyperoxic provocation and 
responses were compared and analyzed for significance over time. The validity of the new 
method was tested by comparing results to those obtained from the ear-clip digital pulse 
oximeter that were recorded simultaneously.  
4.3 Materials and Methods 
4.3.1 Sample 
Ethics clearance was obtained through the Office of Research Ethics at the University of 
Waterloo before commencement of the study and the tenets of the Declaration of Helsinki were 




The sample consisted of 6 males and 6 females of average age 27.1 (range 19-34 years). Subjects 
with any cardiovascular or respiratory disorders were excluded from the study. 
4.3.1.2 Isocapnic Hyperoxic Provocation (Validity) 
The sample consisted of 3 males and 2 females of average age 29.6 (range 24-34 years). Subjects 
with any cardiovascular or respiratory disorders were excluded from the study. 
4.3.2 The Pulse Oximeter 
The pulse oximeter is a non-invasive instrument that indirectly measures the oxygen saturation 
of a patient‟s blood (Figure 4-1)
3
. It was attached to a monitor for easy viewing of the subjects‟ 
oxygenation. A sensor containing small light-emitting diodes (LEDs) facing a photodiode was 
clipped onto the subject‟s earlobe and finger-tip, and a light containing both red and infrared 
wavelengths was passed from one side to the other. Absorption at these wavelengths differs 
significantly between oxyhemoglobin and its deoxygenated form, therefore from the ratio of the 
absorption of the red and infrared light the oxy/deoxyhemoglobin ratio can be calculated by the 
instrument.
3
 The machine displayed the percent hemoglobin molecules in the blood stream 












ODλ, seg (i)=log10 (Iout)          where, I(x) = 1  [ ∑ I(x)· p
k
 ]     
          (Iin  )                              n 
OD   Optical Density 
I(out)   Intensity outside the vessel 
I(in)     Intensity inside the vessel 
pk      Point in/out of vessel  
(centerline, right or left 
boundary) 
4.3.3 Dual Wavelength Method 
Conjunctival vessels were imaged with two narrow band interference filters with specific 
wavelengths using a Zeiss slit lamp at 32x magnification. Images were obtained with filters 
having O2-sensitive and O2-insensitive peak transmissions (440nm (Figure 4-2) and 570nm 
(Figure 4-3), respectively). Images were imported into the image processing application 
ImageJ.
34
 A particular vessel in the region of interest was individually analyzed for each subject 
at their visit. For each image of each subject, a transparency was placed over the computer 
screen. The image was opened up in ImageJ and the vessel of interest was tagged and marked on 
the transparency to ensure the exact spot on the conjunctiva was measured for each subject‟s 
visit. Optical densities (OD) were calculated from the pre-determined vascular segment using the 
average reflected intensities inside (3 points) and outside the vessel (6 points, 1 vessel diameter 
on each side of the vessel). Optical density ratios (ODR, OD440/OD570) were used to calculate 









Figure 4-2 and Figure 4-3: Images of conjunctival vessels obtained with narrow band 





4.3.4 Gas Delivery System 
The sequential re-breathing system (Figure 4-4) that is described elsewhere
35,36
 was made up of a 
fresh gas reservoir and an expiratory gas reservoir that were connected to the patient by one-way 
valves. A single PEEP valve connected the inspiratory and expiratory branches. When the gas in 
the inspiratory limb was depleted, the interconnection between the branches enabled the exhaled 
gas to be re-breathed. To complete the assembly of the system, a gas reservoir was added to the 
expiratory port of a commercial 3-valve oxygen delivery system (Hi-OxSR, ViasysHealthcare, 







Figure 4-4: Schematic diagram showing the components of the sequential re-breathing system 






Each subject attended 1 session of approximately 15 minutes. At the start of the session, the 
subject was seated for 5 minutes prior to commencing the study. The blood oxygen saturation 
levels were monitored with an ear clip probe attached to a digital pulse oximeter while an 
investigator simultaneously imaged the conjunctival vessels with the dual wavelength method. 
Video images of one particular area on the bulbar conjunctiva were recorded for each subject for 
1 minute each at three times of the day (9:00 am, 12:00 pm and 3:00 pm). 
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Once the vessel of interest was decided upon, 3 different areas of the vessel, within 10 pixels of 
each other, were analyzed using the dual wavelength method for each subject at each time point. 
Also, the same area was measured for five consecutive frames. Measurement repeatability was 
assessed across frames and between locations.  
As an additional test of between method concordance, intraclass correlation coefficients were 
calculated
64
 between the gold standard ear SO2 and the dual wavelength method. 
4.3.5.2 Isocapnic Hyperoxic Provocation (Validity) 
Each subject attended 1 session of approximately 60 minutes. At the start of the session, the 
subject was seated for 5 minutes prior to commencing the study. The blood oxygen saturation 
levels were monitored with an ear clip probe and a finger probe attached to a digital pulse 
oximeter while an investigator simultaneously imaged the conjunctival vessels with the dual 
wavelength method. Measurements were recorded at 5 minute intervals. Subjects initially 
breathed air for 10 minutes followed by an isocapnic hyperoxic stimulus (O2) for 20 minutes, and 
then air for a final 10 minute period using the sequential re-breathing circuit. The PETCO2 levels 
were kept at a steady state. 
The flow of O2 was set and monitored by an experienced investigator. Tidal gas concentrations 
were continuously sampled from the mouthpiece using a rapid response critical care gas analyzer 
(Cardiocap 5, Datex-Ohmeda, USA). All data were downloaded to an electronic data acquisition 
system (S5 Collect, Datex-Ohmeda, USA).  
A rapid response critical care gas analyzer (Cardiocap 5, Datex-Ohmeda, USA) was used to 
quantify the relative concentrations of O2 and CO2 in both the inspired and expired gases on a 
breath-by-breath basis. The inspired and end-tidal concentrations of O2 and CO2 were 
downloaded to a personal computer every 5 seconds (S5 Collect software, Datex-Ohmeda, USA) 






Table 4-1: Group mean and SD of inspired O2, expired O2, Inspired CO2, end-tidal CO2, SO2 
(dual wavelength, pulse oximeter – ear and finger clip) as a function of provocation. 





































































There was no significant difference in SO2 between the three locations for the dual wavelength 
method (F(2, 22)=1.25, p=0.31, Figure 4-5). The intraclass correlations between the three 
locations were r(34)=0.93, r(34)=0.56 and r(34)=0.86 for the three times points 9am, 12pm and 
3pm respectively. The interaction between location and time was not significant (F(4, 44)=1.09, 
p=0.37, Figure 4-6) for the dual wavelength method. There was no significant difference across 5 




























Figure 4-6: Interaction between location and time on SO2 
 
Current effect: F(2, 22)=1.25, p=0.31





























Current effect: F(4, 44)=1.09, p=0.37












































Figure 4-7: SO2 across 5 consecutive frames 
 
4.4.2 Isocapnic Hyperoxic Provocation 
There was a significant increase in oxygen saturation on initiation of hyperoxia for all three 
measurement methods. SO2 returned to initial levels when hyperoxia was discontinued (p > 0.05 
from baseline; Figures 4-8, 4-9 and 4-10). 
In response to isocapnic hyperoxic provocation using the dual wavelength method, blood oxygen 
saturation increased from control values (mean ± SD) of 94.0 ± 1.5% to 96.7 ± 1.3% and 
subsequently decreased after withdrawal of hyperoxia to 94.8 ± 0.7% (F(2,8)=5.77, p=0.03). Post 
hoc analysis using Tukey‟s post hoc test indicated the increase from baseline (Air) during 
oxygen provocation (O2) was significant (p=0.03). Blood oxygen saturation values from the ear 
clip pulse oximeter increased from  95.5 ± 1.1% to 98.3 ± 1.1% during hyperoxia and 
subsequently decreased to 96.3 ± 1.3% after withdrawal of hyperoxia (F(2,8)=35.65, p=0.0001). 
Post hoc analysis using Tukey‟s HSD post hoc test for significance indicated the increase from 
baseline (Air) during oxygen provocation (O2) was significant, (p=0.0003), as well as the 
Current effect: F(4, 28)=0.70, p=0.60
Vertical bars denote 0.95 confidence intervals


























decrease from O2 after withdrawal of hyperoxia (p=0.001). Blood oxygen saturation values from 
the finger clip pulse oximeter increased from  97.3 ± 1.1% to 98.8 ± 0.5% during hyperoxia and 
subsequently decreased to 97.3 ± 1.1% after withdrawal of hyperoxia (F(2,8)=11.90, p=0.004). 
Post hoc analysis using Tukey‟s post hoc test indicated the increase from baseline (Air) during 
oxygen provocation (O2) was significant, (p=0.01), as well as the decrease from O2 after 
withdrawal of hyperoxia (p=0.01). 
There was no significant difference between the dual wavelength and ear-clip pulse oximeter 
method (F(1, 11)=0.40, p=0.54, Figure 4-11). The interaction between the two methods (dual 
wavelength and ear-clip pulse oximeter) and time on SO2 was not significant (F(2, 22)=1.83 , 
p=0.18, Figure 4-12). The intraclass correlations between the two methods were r(22)=0.45, 





















































Figure 4-9: Oxygen saturation response to isocapnic hyperoxic provocation using the pulse 












Figure 4-10: Oxygen saturation response to isocapnic hyperoxic provocation using the pulse 
oximeter method with the finger clip probe. 
 Mean 





































































Figure 4-12: Interaction between the two methods and time on SO2 
Current effect: F(1, 11)=0.40, p=0.54
Vertical bars denote 0.95 confidence intervals



























Current effect: F(2, 22)=1.83, p=0.18
Vertical bars denote 0.95 confidence intervals
































A novel imaging method for measuring conjunctival vessel SO2 has been established. By using 
two narrow band interference filters having O2-sensitive and O2-insensitive peak transmissions 
and a slit lamp camera (“dual wavelength method”), a novel extension to previous work on the 
measurement of SO2 was demonstrated.
2,8-10
 The intraclass correlations between locations 




One goal of this experiment was to assess the reliability of the dual wavelength method. By 
measuring multiple locations within a vessel and across several consecutive frames, testing of 
this goal was possible. No significant difference in SO2 between the three locations measured 
over time using this method or across consecutive frames was found. The intraclass correlations 
between the three locations at the three time points were 0.93, 0.56 and 0.86 and across 




Verification of the SO2 measurements was dependent on the accuracy of the external pulse 
oximetry SO2. Clinical studies have demonstrated that the accuracy of pulse oximeters under 
steady state conditions is within ±2%, as long as the measures fall between the range of 100 to 
70% saturation.
39,40
 We chose to use an ear probe as our comparison method, rather than the 
finger probe, because of its ability to respond quickly and accurately to a changing systemic 
arterial saturation.
5
 Confidence regarding the accuracy of the SO2 measurement relied on the 
agreement achieved when it was compared to the ear clip pulse oximeter measurement. When 
comparing the two methods using repeated measures ANOVA, no significant difference was 
found. There was also no significant difference between the methods at either of the time points.  
The intraclass correlations for the two methods were 0.45, 0.10 and 0.11 for the three times 
points. Since both methods demonstrated good reliability, the low ICC values indicate that there 
is variability between methods which may possibly be related to gas exchange delay times due to 





There have been a number of studies that have used a hyperoxic stimulus to investigate vascular 
reactivity in the retina.
1,8,22,25,26,43-45
 These studies investigated a variety of parameters including 
oximetry,
8,22,43
  vessel diameter,
25,44
 and various characteristics of hemodynamics using a variety 
of techniques.
1,26,45
 The technique utilized in this study used the dual wavelength method to 
measure SO2 in conjunctival vessels. Not only did the aforementioned studies measure vascular 
reactivity in the retina, neither of them used an isocapnic hyperoxic stimulus to demonstrate their 
techniques. Using augmented O2 concentrations has been shown to reduce the partial pressure of 
arterial carbon dioxide, as reflected by a change in end-tidal CO2 concentration.
23,46
 It has been 




 and in the retina
48
  that the 
gas delivery system used in this study stabilizes end-tidal CO2 during hyperoxic provocation and 
therefore exclusively reflects vascular reactivity responses to O2. Studies administering 
augmented O2 to assess vascular reactivity generally found higher degrees of vasoconstriction, 
and were as a result of the compounded effect of increased arterial O2 and diminished CO2.
49-51
  
The dual wavelength method was demonstrated using a sequential re-breathing technique. Using 
this technique, elevated levels of O2 were administered while controlling PETCO2 and SO2 with 
three different methods was measured; dual wavelength method, ear-clip pulse oximetry and 
finger-clip pulse oximetry. As shown in Figures 4-8, 4-9 and 4-10, there was a significant 
increase in oxygen saturation on initiation of hyperoxia with all three methods and a return to 
initial values when hyperoxia was discontinued (recovery). 
There have been previously published studies that have investigated SO2 in the retina using a 
hyperoxic stimulus.
8,22,43
 This is the first time that the SO2 in conjunctival vessels has been 
quantified during hyperoxic provocation. These SO2 values and subsequent increases in SO2 
during hyperoxia reported in the present study are comparable to those of previous studies 
involving vessels of the retina
37,43,52
. As expected, the dual wavelength method used to measure 
SO2 in the conjunctival vessels demonstrated a significant increase during hyperoxic provocation 
and a subsequent decrease after withdrawal of the stimulus, similar to the ear and finger pulse 
oximetry methods. The pulse oximeter is a commonly used tool in the clinical setting for 
assessing patients' blood oxygenation status and is regarded as a valid instrument.
2-5
 The values 
from the dual wavelength method and the ear clip pulse oximeter were compared to assess the 
validity of the dual wavelength method. When the two methods were compared, no significant 
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difference was found (p=0.54, Figure 4-11). This demonstrates that the dual wavelength method 
offers good construct validity.
32
  
Ten minutes after hyperoxia was discontinued (recovery) mean SO2 levels for all three methods 
were not significantly different from baseline (p>0.05).  A significant difference between 
hyperoxia and recovery of SO2 was demonstrated with the finger probe pulse oximeter method. 
Differences in recovery response times between methods are unknown and again, may possibly 
be due to gas exchange delay times.
52
 This hypothesis needs further testing.  
It has been demonstrated that a finite time is required for O2 to reach the ocular vasculature due 
to a physiological delay of gas exchange in the lungs and lung-to-eye circulation time.
52
 The 
exact mechanism that manages the reduction in vessel diameter during hyperoxia in order to 
maintain oxygen regulation is not known but various biochemical factors may be responsible.
53
 
The factors include endothelin-1 released from endothelial cells,
54-56
  physical changes to red 
blood cells,
57-59
 superoxide generation and nitric oxide.
60-62
 In addition to a reduction of vessel 
diameter, oxygen supply during hyperoxia can be controlled by a change in wall shear rate via an 




This is a novel study that utilized an isocapnic hyperoxic stimulus to provoke conjunctival 
vascular reactivity while controlling PETCO2 to demonstrate the dual wavelength method.  
The application of the dual wavelength method was demonstrated and optical density ratios can 
be used in a reliable manner for relative oxygen saturation measurements. This valid method 
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5. Oxygen saturation, red blood cell velocity and bulbar 
conjunctival redness in conjunctival vessels  
5.1 Overview 
Purpose: The aim of this experiment was to examine variations in ocular redness levels, red 
blood cell velocities and oxygen saturation levels over time in clinically healthy participants. An 
ancillary question was to examine these measures in an older age stratum as well as a younger 
age stratum and to compare differences between the groups. Methods: The sample consisted of 
14 healthy participants with average age of 34.7 years (range 20-61 years). Participants attended 
eight separate visits over the course of a day. Levels of bulbar conjunctival redness, red blood 
cell velocity and blood oxygen saturation were measured on a vessel of interest. Results: From 
baseline, the group mean redness and oxygen saturation did not change significantly over time (p 
> 0.05). There was a significant difference in the group mean red blood cell velocity values over 
time (p = 0.01). There was no significant difference between age strata for all three measures. 
Conclusions: The results of this study support the theory of metabolic regulation. The lack of 
any significant change across time for redness and oxygen saturation along with significant 
changes in red blood cell velocity substantiates this notion.  
5.2 Introduction 
A function of the circulatory system is to provide tissues with the required amount of oxygen and 
nutrients vital for cell function.
1,2
 Ocular circulation assessment has evolved from a subjective 
physical description of the visible vessels to direct and indirect quantitative measurement of a 
number of ocular hemodynamic parameters. Today, the techniques available for hemodynamic 
assessment (outlined in Chapter 1) examine various aspects of the ocular circulation. These 
methods have the potential to contribute greatly to our understanding of normal hemodynamics.  
Regardless of our understanding of the significance of circulation, we know little of the factors 
(and interaction of these factors) influencing this on the ocular surface. Quantitative and non-





 By measuring red blood cell velocity, oxygen saturation and ocular surface 
redness in the conjunctival vessels we are able to study the changes that occur in the circulation 
and the levels of oxygen delivery and saturation over many health states and conditions. 
Regulation of blood flow is necessary to adapt to different internal and external conditions. This 
regulation also compensates for varying perfusion pressures, adapts to metabolic activity and 
helps to maintain a constant ocular temperature.
7
 By and large, red blood cell velocity is 
regulated by the cardiac output, which is mainly controlled by the autonomic nervous system and 
circulating hormones.
7
 The resistance of local vessels is controlled by the vascular endothelial 
cells. The endothelial cells achieve desired changes in resistance by releasing vasoactive 
molecules such as endothelin-1 (vasoconstriction) and nitric oxide (vasodilation). The retina is 
regulated mainly by the neural and glial cells.
8
 The choroidal circulation is regulated by the 
autonomic nervous system and circulating hormones.
9,10
 The optic nerve head is regulated by 
endothelial cells and circulating hormones.
11
 
The mechanisms underlying vessel resistance are not completely understood. Although 
constriction and dilation are regulated by the autonomic nervous system, circulating hormones 
and vasoactive molecules, other mechanisms may also be involved. It has been demonstrated that 
organs and local tissue require specific levels of blood oxygen saturation for optimal function 
and therefore blood flow must be adequately regulated to achieve this.
7,12
 Therefore, required 
oxygen levels are maintained by the organs‟ strong capacity to regulate.
7,12-15
 
The capacity of an organ (e.g. brain) to function optimally in a physiological manner has been 
demonstrated to decline with age.
16,17
 The age-related physiological declines that occur include, 
reductions in growth and insulin-like growth factors, increases in vascular resistance, reductions 
in distensibility within vessels, and compromises to the endothelium-dependent vascular relaxant 
mechanisms.
18-20
 It has been demonstrated in the cerebral vessels that the cerebral oxygen 
reserve remains fairly stable because the vessels regulate regional blood flow to accommodate 
changes in perfusion and arterial oxygenation
21,22
 but, it has also been demonstrated that with age 
the vessels lose some of their ability to maintain this reserve.
16,17
 As a result, oxygen extraction 
from capillary blood must increase to maintain cerebral oxygen metabolism and tissue function, 






As age increases, the systemic vascular resistance increases and contributes to the disturbed 
capacity of local blood vessel dilation.
24
 The result of disturbed vasodilation can contribute to 
reductions in ocular flow,
24,25
 as well as limit the ability of the vessels to increase flow in 
response to physiological challenges such as hypoxemia.
24
 In addition, aging has been 
demonstrated to reduce aqueous inflow and outflow,
26
 decrease the mobility of the ciliary 
muscle,
27
 decrease the optical performance of the eye,
28
 increase ocular surface redness,
29
 and 
gradually enlarge the optic nerve head cup and thin the neuroretinal rim.
30,31
  
The aim of this study was to characterize  conjunctival red blood cell velocity, oxygen saturation 
and bulbar conjunctival redness in a group of clinically normal subjects. An additional initiative 
was to examine these measures in two age strata. 
5.3 Hypothesis 
It was expected that there would be no changes in ocular surface redness, red blood cell velocity 
and blood oxygen saturation over time in the healthy individuals. In the comparison between age 
strata, it was expected that the older age stratum would have increased levels of redness, and 
decreased red blood cell velocities when compared to the younger age stratum. It was expected 
that the blood oxygen saturation levels in the older aged stratum would be lower than the 
younger aged stratum. 
5.4 Materials and Methods 
5.4.1 Sample 
Ethics clearance was obtained through the Office of Research Ethics at the University of 
Waterloo before commencement of the study. Eligible subjects signed an informed consent 
document before enrolment in the study.  
The eligibility of participants was determined at a screening appointment. The sample consisted 
of 14 healthy participants with an average age of 34.7 years (range 20-61 years). The participants 
were also evenly divided into two age strata (between 18-30 yoa and 31-62 yoa) with average 
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age of 25.1 (range 20-28 years) and 45.6 (range 32-61 years) and assessed for differences 
between them. Subjects with any vascular disorders were excluded from the study. 
5.4.2 Redness Measurements 
For the measurements of conjunctival hyperemia, chromaticity (u‟) values were taken by the 
SpectraScan PR650 Spectrophotometer (Figure 5-1). The photometer and a modified slit-lamp 
were mounted onto a table-top device.  
The PR650 measures luminance and chromaticity. It measures the absolute intensity at each 
wavelength and then calculates the equivalent CIE value. The modified slit-lamp mount 




Figure 5-1: a) SpectraScan PR650 Spectrophotometer; b) Photometer and illumination set up 
 
5.4.3 Blood Oxygen Saturation Measurements 
Please refer to chapter 4.3.3 of this thesis for SO2 measurement description. 
 
86 
5.4.4 Red Blood Cell Velocity Measurements 
Videos were taken with the Handy Alpha, Hyper Micro Color CCD Camera with LED lighting 
(Plumnet Co. Ltd.
©
, Japan) which was mounted on a modified slit-lamp (Figure 5-2). The 
magnification of the camera (Figure 5-3) was altered by adding on 2 adapters.  The modified slit 
lamp mount contained the Handy Alpha camera, a chin rest and a velcro strap that wrapped 
around the subject‟s head. The AV cable supplied with the camera was connected to a desktop 















Figure 5-3: Handy Alpha camera 
 
Conjunctival vessels of healthy individuals were digitally imaged at 30 frames per second with 
high enough magnification (2 adapters, approximately 144x magnification
32
) to clearly resolve 
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movement of the blood within the vessel. The videos were then coded in AVI format with 7 
frames per second, 720x480 pixels, 24 bits per pixel. For each video one vessel was selected and 




At 8 measurement sessions, 1 hour apart, the first occurring at 9:00 am, redness, SO2 and RBC 
velocity video data were acquired. Each measurement was recorded under controlled 
illumination.  
The participant sat at each instrument and looked at a target to their left or right. This was for 
the temporal measurements of either the right or the left eye respectively (depending on which 
eye was randomly assigned the study eye). The examiner positioned the instrument on the 
temporal bulbar conjunctiva and focused on the “vessel of interest” (VOI). Participants 
remained in the building during the entire experiment. 
5.4.5.1 Redness Measurement Procedures 
The participants‟ temporal conjunctiva was viewed with the slit lamp, a vessel was chosen as the 
VOI and was used for all subsequent measurements.  
The chromaticity (CIEu‟) of a small fixed area surrounding the participant‟s VOI was measured 
with the photometer under controlled illumination. The light was turned on just prior to the 
measurement and turned off just after.  
The participant sat at the photometer and looked at the target (Figure 5-4). The examiner looked 
through the eye piece and positioned a black measuring spot (approximately 5 mm diameter) on 
the temporal bulbar conjunctiva on top of the VOI. The measuring spot was also aimed 
approximately 2mm from the limbus. There were five measurements of redness taken on both 
eyes at each visit and averaged. To ensure consistent results, no adjustments to the eye piece 









Figure 5-4: Participant set up at the photometer with viewing targets to the left and right (red and 
green light). 
 
5.4.5.2 Blood Oxygen Saturation Procedures 
The participants‟ VOIs were recorded with the slit-lamp under controlled illumination. The 
participant sat at the slit lamp and looked at one of the targets. The examiner positioned the slit 
lamp so they were able to focus on the temporal bulbar conjunctiva and the VOI. The 
investigator imaged the VOI with the dual wavelength method detailed in Chapter 4. The video 
images of the VOI on the bulbar conjunctiva were recorded for each participant for 1 minute 
each at all visits during the day.  
 
5.4.5.3 Red blood cell velocity measurement procedures 
The participant sat at the slit lamp mount and looked at a specific target. The examiner 
positioned the camera on the temporal bulbar conjunctiva and focused on the VOI. While 
monitoring the video on the computer screen, the examiner recorded several minutes of video in 
order to ensure good quality and an ample number of frames. To ensure consistent results the 
participant‟s head was strapped in with a Velcro strip across the back of their head and they 
were instructed to be conscious of minimizing any small movements.  
Videos were imported into the video processing utility VirtualDub (v1.8.8, Cambridge, MA) 
and cropped into image sequences of manageable size. The image sequences were converted to 
AVI files. All files were pre-processed as described below and velocity was estimated.  
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5.4.5.3.1 Pre Processing and RBC Velocity Estimation 
Please refer to chapter 3.3.1.1 and 3.3.1.2 of this thesis for pre processing and RBC velocity 
estimation description. 
5.4.5.4 Data Analysis 
The group of 14 healthy participants was assessed for differences across the 8 visits for all three 
measures using repeated measures ANOVA (Statistica 7; Statsoft, Tulsa, OK). The group of 14 
participants was also divided into two age strata (7 participants between 18-30 yoa and 7 
participants between 30-62 yoa) and assessed for differences between them across the 8 visits for 
all three measures using a mixed ANOVA. 
5.5 Results 
5.5.1 Redness  
The effect of age, time and their interaction on redness is shown below. The redness of the 
younger and older strata ranged from 0.267 ±0.004 to 0.269 ± 0.004 and 0.272 ± 0.008 to 0.276 
± 0.007, respectively. The redness over time ranged from (mean ± SD) 0.270 ± 0.006 to 0.272 ± 
0.007.  
There was no effect of age (F(1, 12)=3.57, p>0.05; Figure 5-5). The redness over time was not 
significant (F(7.91)=1.31, p>0.05; Figure 5-6) . The interaction between age and time on redness 






Figure 5-5: Bulbar conjunctival redness sorted by age 
 
Current effect: F(1, 12)=3.57, p=0.08
Vertical bars denote 0.95 confidence intervals














































Figure 5-7: Interaction between age and time on redness 
 
Current effect: F(7, 91)=1.31, p=0.26
Vertical bars denote 0.95 confidence intervals


























Interaction of Redness and Age
Current effect: F(7, 84)=0.87, p=0.53
Vertical bars denote 0.95 confidence intervals
 18-30 yoa
 31-62 yoa





























SO2 stratified by age
Current effect: F(1, 12)=4.14, p=0.06
Vertical bars denote 0.95 confidence intervals




























5.5.2 Oxygen Saturation Measurements 
The effect of age, time and their interaction on oxygen saturation is shown below. The oxygen 
saturation of the younger and older strata ranged from 97.1 ± 1.3 to 98.7 ± 2.2 and 98.3 ± 1.4 to 
99.7 ± 2.0, respectively. The group mean SO2 values over time (mean ± SD) ranged from 98.2 ± 
2.2 to 99.2 ± 2.1.  
There was no main effect of age (F(1,12)=4.14, p>0.05; Figure 5-8). The SO2 over time was not 
significant (F(7,91)=0.60, p>0.05; Figure 5-9). The interaction between age and time was not 









































Figure 5-10: Interaction between age and time on SO2 
Current effect: F(7, 91)=0.60, p=0.76
Vertical bars denote 0.95 confidence intervals






























Current effect: F(7, 84)=0.61, p=0.74
Vertical bars denote 0.95 confidence intervals
 18 - 30 yoa
 31 - 62 yoa
































RBC velocity stratified by age
Current effect: F(1, 5)=2.83, p=0.15
Vertical bars denote 0.95 confidence intervals







































5.5.3 Red blood cell velocity  
The effect of age, time and their interaction on RBC velocity is shown below. The RBC velocity 
in the younger and older strata ranged from 18.9 ± 7.9 to 49.0 ± 15.3 and 17.8 ± 14.1 to 45.8 ± 
14.9, respectively. The group mean velocity values over time (mean ± SD) ranged from 21.8 ± 
23.0 to 38.8 ± 23.6.  
There was no main effect of age (F(1,5)=2.83, p >0.05; Figure 5-11). The RBC velocity over 
time was significant (F(7,42)=3.17, p=0.01; Figure 5-12). The velocity was less in the first few 
measurements and higher in the last few measurements. The significance was between the eighth 
measure and the first and fourth measures (Tukey HSD; p = 0.002 and p = 0.02, respectively). 
















Current effect: F(7, 42)=3.17, p=0.01
Vertical bars denote 0.95 confidence intervals




















































Figure 5-13: Interaction between age and time on RBC velocity 
 
Current effect: F(7, 35)=0.46, p=0.86
Vertical bars denote 0.95 confidence intervals
 18-30 yoa
 30-62 yoa





































The use of novel methods for the measurement of red blood cell velocity and oxygen saturation 
within the conjunctival vessels on the surface of the eye has been demonstrated. The present 
study investigated conjunctival redness, oxygen saturation and RBC velocity in a group of 
healthy participants. The change in redness and oxygen saturation over time in the group of 
healthy participants (n = 14) was not significant. We did however find a change of RBC velocity.  
Since the participants in this particular study were not suffering from vascular dysregulation, it is 
likely that their vessels were under normal, local, regulatory control and the lack of any 
significant change in oxygen saturation over time was expected. Oxygen saturation was 
hypothesized not to vary significantly since cerebral vessels have been previously shown to 
regulate regional blood flow to accommodate changes in perfusion and arterial oxygenation in 
order to keep SO2 levels within a specific range.
21,22
 The results of this study demonstrated that 
over time, SO2 did not change, supporting this theory of vascular regulation.  
A primary function of the vasculature is homeostatic regulation during ordinary instances and 
especially during times when various stimuli are applied to the system.
7,33,34
 The results of this 
study support this notion. If regulation does not occur according to the needs of the tissue it is 
referred to as vascular dysregulation.
7
 During the regulation of any parameter, several systems 
are involved in such a way that the dysfunction of one of the systems would lead to 
compensation by another. The regulations of different parameters are frequently interconnected. 
Blood flow, for instance, is involved in the regulation of oxygen supply, transport of nutrients 
and regulation of temperature and volume. The vascular system is significantly regulated on 
different levels such as in large or small arteries, capillaries and veins.
35
 Vascular dysregulation 
merely means that this local adaptation does not meet the requirements of the body or its 
corresponding tissues. This insufficiency may be local, such as damage to the endothelial cells in 
the vessel wall (e.g. atherosclerosis), may be secondary to an underlying disease (e.g. diabetes) 
or, may be a natural tendency to react differently to various stimuli (e.g. cold temperatures).  
A previous study has shown significant changes in ocular surface redness across time.
36
 These 
significant changes were accounted for by a cascade of electro-chemical reactions within the 
body
37,38
, the metabolic effects of hypoxia during sleep
39
, cytokines and mediators
40
 that cause 
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inflammatory and immune-mediated reactions that contribute to ocular inflammation
41
 and, 
several neurotransmitters, hormones and chemicals that have potent effects on the vessels within 
the eye that cause either vasodilation or, vasoconstriction.
1
 The previous study was different 
from this present study in that the number of hours each participant slept and the food they ate 
was tightly controlled. These differences could account for the lack of significance found in this 
experiment. Although we did not expect or find significance, our redness values were 
comparable in range.
36,42
 The measurement area of redness in this study was different than the 
SO2 and RBC velocity measure in that the former includes a total area of 19.6 mm
2
 versus a 
single point along the vessel of interest (VOI). The area includes the VOI as well as deeper and 
additional vessels within that 19.6mm
2
 area. The latter two measures were an estimation within 
the VOI alone. When trying to understand the interconnection of the regulation between the three 
measures, this must be taken into account. Although “global” redness (redness in an area of 
19.6mm
2
) may be expected to change significantly over time (and has previously been 
demonstrated), the redness as a function between the ratio of vessel to background for one vessel 
was not hypothesized to change significantly. This notion will help in the understanding of the 
changes or lack of changes in the measures of SO2 and RBC velocity.  
There are no experimental comparisons of the blood velocity or oxygen saturation on the anterior 
ocular surface. The values obtained for velocity and SO2 were comparable to previous studies 




 and cerebral vessels
34
. 
Blood flow comparisons are somewhat difficult because of circulation differences within specific 
ocular regions.
46
 Moreover, change in velocity across measurements was not expected to occur 
since in normal eyes, autoregulation keeps blood flow relatively constant.
47-51
  The eye requires 
constant perfusion during dynamic changes in blood pressure, intraocular pressure and ocular 
perfusion pressures. Since the results demonstrate a significant change in RBC velocity over 
time, it can be assumed that there were changes occurring with respect to the oxygen demands on 
the tissue and the vessels had to accommodate the blood flow in order to maintain a specific 
level of oxygenation.
21,22
 The blood flowing through the majority of the vessels (specifically the 
VOI) that were imaged on the conjunctival surface consist of RBCs that traverse the vessel 
column in single file. The diameter of the column itself is quite narrow, to the point that the 
RBCs cannot line up side by side. Because of regulation, the vessel was not expected to increase 
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or decrease significantly in calibre. The expectation for the lack of a significant change in calibre 
of the vessel supports the hypothesis of a lack in change of redness over time (in the VOI).  
When the groups were sorted by age and compared, a few interesting effects were found. There 
were no significant differences found between age strata for either of the variables. However, 
there was a strong trend towards significant differences in redness and oxygen saturation. Both 
trends indicated higher levels of redness and higher levels of circulating oxygen for the older age 
stratum. On average, the redness was 2.2% higher and the SO2 was 0.89% higher for all time 
points for the older cohort. The trend for the older age stratum to have a greater level of redness 
is consistent with a study that found redness increases with each decade in life by approximately 
0.1 units on the McMonnies grading scale.
29
 It was speculated that the gradual increase in 
redness with age may be attributable to a reduction in arteriolar wall muscle tone.
29
  
Again, although not significant, our results showed a trend for RBC velocity to be lower in the 
older age stratum. On average, the RBC velocity was 30.0% higher across all points for the 
younger age stratum. Under normal, healthy circumstances, the cerebral oxygen reserve remains 
fairly stable because the cerebral vessels regulate regional blood flow to accommodate changes 
in cerebral perfusion and arterial oxygenation
21,22
 but with age, the cerebral vessels lose some of 
their ability to maintain this reserve of oxygen, which declines on average by 5% to 10% 
between the ages of 40 and 75.
16,17
 Such regional decreases in blood flow may result from 
disturbed vasodilatation of local blood vessels due to increased vascular resistance. In any case, 
the result of disturbed vasodilation is a limited ability to increase flow in response to challenges 
like hypoxemia. As a result, oxygen extraction from capillary blood must increase to maintain 
cerebral oxygen metabolism and tissue function, and this increased oxygen extraction is reflected 
as a decrease in measured regional cerebral SO2.
23
 The trend for the older age stratum to have a 
greater level of oxygen may be indicative of the inability of the tissue to extract the available 
oxygen. Conversely, a lower level of available oxygen in the younger aged stratum may be 
indicative of good and/or sufficient levels of oxygen extraction by the tissue. The lower RBC 
velocity demonstrated in the older age stratum coincides with the higher levels of SO2. With high 
levels of available oxygen, RBC velocity would not be required by the system to increase. 
The systemic increase of vascular resistance that arises with age may also be involved in the 
reduction of ocular flow.
24
  Increasing age inevitably causes widespread physiological declines 
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that reduce functional capacities and increase susceptibility to disease via reductions in growth 
and insulin-like growth factors, increases in vascular resistance, reduction of distensibility within 
vessels, and compromises the endothelium-dependent vascular relaxant mechanisms.
18-20
 These 
declines essentially include many alterations within the eye. For example, ageing reduces 
aqueous inflow and outflow,
26
 decreases the mobility of the ciliary muscle,
27
 decreases the 
optical performance of the eye,
28
 and gradually enlarges the cup and thins the neuroretinal 
rim.
30,31
 The consequence of these numerous effects of aging on the eye is to concentrate 




In summary, these results are for a small cohort of healthy adults and further testing would be 
required to discern the exact relationship between the variables and the aging eye. These results 
support the theory of vascular regulation under normal circumstances. In healthy individuals it 
was demonstrated that although significant variations in RBC velocity were recorded, levels of 
SO2 remained stable.  
It is recognized
1,2,24,35
 that aging, disease, or a prolonged vascular stress alters the normal vessel 
anatomy or reactivity in various ways and therefore furthering these findings in a much larger 
cohort of healthy individuals is essential.  
5.7 Conclusions 
In summary, the participants in this particular study did not suffer from any known causes that 
would contribute to vascular dysregulation and therefore it is plausible that their vessels were 
under normal, local, regulatory control. The results of this study support the theory of metabolic 
regulation. The lack of any significant change across time for redness and oxygen saturation 
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6. Conjunctival redness, red blood cell velocity and oxygen 
saturation in participants after instillation of a topical 
ophthalmic decongestant 
6.1 Overview 
Purpose: The aim of this experiment was to examine the ocular redness levels, red blood cell 
velocities and oxygen saturation levels in clinically healthy participants when a topical 
ophthalmic decongestant was instilled onto the eye and to demonstrate the validity of the use of 
two novel techniques. Methods: The sample consisted of 7 healthy participants with an average 
age of 35 years (range 25-61 years). Participants attended three separate visits during a 60 minute 
session. Bulbar conjunctival redness, red blood cell velocity and blood oxygen saturation were 
measured on a vessel of interest, pre-instillation, just after insertion and, 10 minutes after 
insertion of a topical ocular decongestant. Significant differences between the three measures 
were assessed and correlations between the three parameters were reported. Results: From 
baseline, the group mean redness values increased slightly from 0.268 ± 0.004 to 0.271 ± 0.004 
at drop instillation. The group mean red blood cell velocity and oxygen saturation values 
changed from 35.2 ± 46.9 µm/s and 98.1 ± 2.6 % at baseline to 28.8 ± 17.0 µm/s and 98.6 ± 1.6 
% at drop instillation, respectively. After instillation redness values decreased to 0.265 ± 0.01 
(p=0.01). The red blood cell velocity and oxygen saturation were 31.3 ± 28.1µm/s and 97.4 ± 2.6 
% at the post measurement, respectively. These two measures did not change significantly (p > 
0.05). There was a moderate significant correlation between SO2 and red blood cell velocity just 
after drop insertion (r = 0.79). Conclusions: This study supports the literature regarding 
regulation of the microvasculature during the use of various stimuli. The results demonstrated 
that oxygen saturation levels remain stable even when a significant decrease in ocular redness is 
measured. The novel techniques used in this experiment demonstrated the expected action of the 




The circulation in the eye is regulated differently in various local tissues but the common goal is 
to provide these tissues, regardless of location, with a required amount of oxygen and nutrients 
essential for cell function.
1-4
 A better understanding of normal vascular physiology of the eye 
and its changes during provocation or disease is required. By studying the effects of various 
agents on normal microcirculatory hemodynamics necessary insight into vascular reactivity may 
be provided. 
The availability of research tools to study and quantify various hemodynamic parameters on the 
ocular surface is limited. The novel techniques presented in Chapter 3 and Chapter 4 of this 
thesis have the potential to provide the necessary means to explore vascular physiology and 
reactivity on the ocular surface. 
There are only 2 easily accessible areas for non-invasive in vivo microcirculation research in 
human participants: the nail fold capillary bed and the conjunctival microcirculation.
5-8
 Vascular 
reactivity can characterize a hemodynamic response of the vasculature and has been 




, the use of 
topical vasoactive agents
14,15
  and  hypoxia
16
.  
Topical decongestants are over the counter products that are sometimes used to initiate 
vasoconstriction of ocular surface vessels in order to relieve itching and redness due to pollen, 
ragweed, grass, animal hair, and dander.
17,18
  
Decongestant activity has a direct α-adrenergic action or histamine H1-blocking action on the 
superficial conjunctival vasculature.
18,19
 Adrenergics will stop vasodilation and/or cause 
vasoconstriction of the vessels and mydriasis by interacting with the α1-receptors on the blood 
vessels.
17,18
 Drug interaction with the receptors will help offset vasodilation and other signs and 
symptoms of a mild inflammatory condition.
17,18
  Some common decongestants include 
phenylephrine and imidazole compounds. 
Imidazole compounds such as, naphazoline, tetrahydrozoline and oxymetazoline are 
sympathomimetic agents with α-adrenergic activity.
18
 They can act as vasoconstrictors with a 
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rapid action in reducing swelling when applied to mucous membranes. They act on α-receptors 
in the arterioles of the conjunctiva to produce constriction, resulting in decreased congestion.
18,19
  
The aim of this experiment was to examine the RBC velocity, oxygen saturation levels and 
ocular redness levels in clinically healthy subjects when a topical ophthalmic decongestant
14,15
 
was instilled onto the eye. By using the novel techniques to quantify the expected changes in the 
vasculature after the instillation of a topical vasoconstrictor the utility and validity of these 
techniques will be demonstrated. Correlations between variables were also tested before and 
after vasoconstrictor use. 
6.3 Hypothesis 
The hypothesis of this study is that after the instillation of a topical vasoconstrictor onto the 
ocular surface, a decrease in ocular redness and RBC velocity with no change in oxygen 
saturation levels would be demonstrated. A decrease in ocular redness would demonstrate the 
action of the topical vasoconstrictor and the lack of change in SO2 during the action of the 
vasoconstrictor would demonstrate metabolic regulation.  
6.4 Materials and Methods 
6.4.1 Sample 
Ethics clearance was obtained through the Office of Research Ethics at the University of 
Waterloo before commencement of the study. Eligible participants signed an informed consent 
document before enrolment in the study.  
The eligibility of participants was determined at a screening appointment. The sample consisted 
of 7 healthy participants with an average age of 35 years (range 25-61 years). Subjects with any 




The tetrahydrozoline topical ophthalmic decongestant used was Visine® Original and is 
available over the counter. Visine contains tetrahydrozoline 0.05%, a direct acting 
sympathomimetic or nonselective α-adrenergic agonist.  
6.4.3 Redness Measurements 
Please refer to chapter 5.4.2 of this thesis for redness measurement description. 
6.4.4 Blood Oxygen Saturation Measurements  
Please refer to chapter 4.3.3 of this thesis for blood oxygen saturation measurement description. 
6.4.5 Red Blood Cell Velocity Measurements 
Please refer to chapter 5.4.4 of this thesis for RBC velocity measurement description. 
6.4.6 Procedures 
The participants attended three separate visits during the 60 minute session. At each session, 
redness, dual wavelength images and red blood cell velocity videos were taken on the VOI. The 
variables were measured at baseline, immediately following drop instillation (Visine®) and 10 
minutes later.  
6.4.6.1 Redness Measurement Procedures 
Please refer to chapter 5.4.5.1 of this thesis for redness measurement procedure description. 
6.4.6.2 Blood Oxygen Saturation Measurement Procedures 
Please refer to chapter 5.4.5.2 of this thesis for SO2 measurement procedure description. 
6.4.6.3 Red blood cell velocity measurement procedures 





6.5.1 Redness  
The group mean redness (CIEu‟) increased slightly from 0.268 ± 0.004 to 0.271 ± 0.004 at drop 
instillation and significantly decreased to 0.265 ± 0.006 at the post measurement (Figure 6-1). 
These variations in redness over time were statistically significant (F(2,12)=6.18, p=0.01). The 











Figure 6-1: Redness over time 
 
6.5.2 Oxygen Saturation Measurements 
The group mean oxygen saturation was constant over time (Figure 6-2). SO2 was 98.1 ± 2.6 %, 
98.6 ± 1.6 % and 97.4 ± 2.6 % at each time point. These variations in SO2 across visits were not 
statistically significant (F(2,12)=0.77, p>0.05). 
 
Current effect: F(2, 12)=6.18, p=0.01
Vertical bars denote 0.95 confidence intervals



































Figure 6-2: Blood oxygen saturation over time 
 
6.5.3 Red blood cell velocity  
Red blood cell velocity was 35.2 ± 46.9 µm/s, 28.8 ± 17.0 µm/s and 31.3 ± 28.1µm/s at each 
time point (Figure 6-3). These variations in RBC velocity across visits were not statistically 









Current effect: F(2,12)=0.77, p=0.49
Vertical bars denote 0.95 confidence intervals




































Figure 6-3: Red blood cell velocity over time 
 
6.5.4 Correlations 
A correlation matrix for all variables is displayed in Table 6-1. There was a significant 
correlation found between SO2 and red blood cell velocity upon drop insertion (r = 0.79; p<0.05) 
and between redness pre and post drop insertion (r=0.80; p<0.05). The correlation
20
  between 
redness and red blood cell velocity post drop was r = 0.51.  
Partial correlations between two variables were completed on correlation values above an r of 
|0.50| since correlation values below this level are considered weak.
21,22
 When redness was 
controlled at the “drop” time point r between SO2 and red blood cell velocity remained the same 
(r = 0.79; p<0.05, Table 6-2). When SO2 was controlled at the “post drop” time point r increased 




Current effect: F(2,12)=0.18, p=0.84
Vertical bars denote 0.95 confidence intervals























































1.0 0.39 0.80 0.54 0.23 0.29 0.04 0.54 0.66 
Redness 
Drop 
 1.0 0.26 0.37 -0.26 -0.21 -0.30 -0.13 0.13 
Redness 
Post 
  1.0 0.15 0.10 -0.14 -0.20 0.40 0.51 
SO2 
Pre 
   1.0 0.32 0.68 -0.19 0.17 0.17 
SO2 
Drop 
    1.0 0.07 0.33 0.79 0.07 
SO2 
Post 
     1.0 0.18 0.07 0.3 
RBC vel. 
Pre 
      1.0 0.65 0.61 
RBC vel. 
Drop 
       1.0 0.61 
RBC vel. 
Post 







Table 6-2: Partial correlation matrix between SO2 and RBC velocity (redness controlled)  
Controlled Variable: Redness (Drop) 
 SO2 RBC Velocity 
SO2 1.0 0.79 
RBC Velocity  1.0 
 
Table 6-3: Partial correlation matrix between redness and RBC velocity (SO2 controlled)  
Controlled Variable: SO2 (Post Drop) 
 Redness RBC Velocity 
Redness 1.0 0.59 
RBC Velocity  1.0 
 
6.6 Discussion 
After applying a topical ophthalmic decongestant to the ocular surface a significant group mean 
reduction in redness post-insertion of the drop over time was demonstrated. The red blood cell 
velocity and SO2 values did not change over time. No high
20
 correlations between any variables 
occurred.  
Given that the goal of the vasculature is to maintain a level of homeostatic regulation when a 
stimulus is applied to the system,
1,23,24
 the lack of a significant change in SO2 was not surprising. 
When the vascular system encounters a stimulus or is under duress, the vessels accommodate in 
such a way to aid in the maintenance of a stable oxygenation level.
25,26
 The action of the 
vasoconstrictor was demonstrated with a significant reduction in redness over time. Despite the 
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It was hypothesized that after the instillation of the topical decongestant there would be a 
significant decrease in redness due to the constriction of the vessels and this was demonstrated. 
Decongestant activity has previously shown to have a direct α-adrenergic action on the 
conjunctival vasculature and causes vasoconstriction of the vessels by interacting with the α1-
receptors of the blood vessels.
18,19
 The reduction in redness demonstrated the action of the 
decongestant.  
It was hypothesized that a decrease in red blood cell velocity would be demonstrated given the 
vasoconstrictive action of the decongestant. By constricting the vessels, the vascular resistance 
increases.
28
 With an increase in vascular resistance, a decrease in red blood cell velocity was 
hypothesized. It was demonstrated in this experiment that there was a significant decrease in 
redness and was likely as a result of the decrease in the calibre of the vessels. As mentioned in 
Chapter 5, the measurement area of redness in this study was different than the SO2 and RBC 
velocity measure in that the former includes a total area of 19.6 mm
2
 versus a single point along 
the vessel of interested (VOI). The area includes the VOI as well as deeper and additional vessels 
within that 19.6mm
2
 area. The latter two measures were an estimation within the VOI itself. 
Although it was completely expected (and demonstrated) that redness would decrease “globally” 
with the use of the topical decongestant, it is possible that the amount the VOI itself decreased in 
diameter was not enough to increase resistance to a level where a significant decrease in RBC 
velocity would be measured. This is plausible since the current diameter of the vessel is already 
quite small and a further constriction may not be possible.  
The correlation between SO2 and RBC velocity just after drop instillation was significant (r = 
0.79). This correlation is quite interesting since a function of the vasculature is to continually 
maintain specific levels of oxygenation via changes in vessel calibre and velocity/flow.
1,28-30
 
Therefore, it is expected that these two variables should be highly correlated. After removing the 
contribution of redness (partial correlation) on the correlation between SO2 and RBC velocity 
just after drop instillation, the correlation value did not change. This suggests that redness does 
not contribute any variance to the correlation between SO2 and RBC velocity. Again, the 
definitive effect of redness on the SO2 and RBC velocity measures in the VOI is difficult to 
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discern since the redness measure does not only involve the VOI but between those two variables 
at that particular instant, no effect was evident. 
The correlation between redness and RBC velocity post drop insertion was 0.51 (p>0.05). This 
suggests that when redness levels are low (brought on by the action of the vasoconstrictor) a 
correlation to RBC velocity is apparent. This notion seems somewhat plausible in that with a 
smaller calibre, the effect on RBC velocity would be greater because of an increase in vascular 
resistance. After removing the contribution of SO2 on the original correlation between redness 
and RBC velocity, the r value increased to 0.59. An increase in the strength of the correlation 
suggests that SO2 was masking some of the correlation which exists in its absence. 
6.7 Conclusions 
This study supports the literature regarding metabolic regulation of the microvasculature during 
the use of various stimuli. The results demonstrated that oxygen saturation levels remain stable 
even when a significant decrease in ocular redness is measured. The novel techniques used in 
this experiment demonstrated the expected action of the decongestant further contributing to 
their application and validity. 
Many disciplines have investigated changes in blood flow and blood oxygen saturation levels 
while using various stimuli to assist in the pathological understanding of vascular reactivity. The 
bulbar conjunctiva provides an ideal, readily accessible, microvascular bed for in vivo research. 
In future, these techniques can possibly be used to noninvasively study vascular changes in the 
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7. Oxygen saturation, red blood cell velocity and bulbar 
conjunctival redness in participants who wear contact lenses 
7.1 Overview 
Purpose: Ocular redness is the principle clinical sign of an inflammatory response affecting the 
anterior segment of the eye. The aim of this experiment was to examine ocular redness, red blood 
cell velocity and oxygen saturation in participants who were habitual soft contact lens wearers. 
An ancillary question was to compare these outcomes in silicone (SH) and non-silicone hydrogel 
wearers. Methods: The sample consisted of 11 healthy participants (control group) who did not 
wear contact lenses with an average age of 34.5 years (range 24-57 years) and 11 healthy 
participants (study group; 6 SH and 5 hydrogel) who habitually wore contact lenses with an 
average age of 32.3 years (range 23-55 years). Participants were measured 8 times over the 
course of a day. Bulbar conjunctival redness, red blood cell velocity and blood oxygen saturation 
were measured. Results: When comparing the study and control groups, no significant 
difference in redness or SO2 over time was found (p > 0.05). RBC velocity over time was found 
to be significantly different between groups (p = 0.04). A significant effect between the 
interaction of group and time on redness and RBC velocity was demonstrated (p = 0.02 and p = 
0.02, respectively). When comparing the two study groups (SH vs. hydrogel) no significant 
difference across either measure over time was found (p > 0.05). A significant difference in the 
interaction between group and time on RBC velocity was found (p = 0.05). Conclusions: In 
summary, the participants in the study group were habitual contact lens wearers that had lower 
RBC velocities when compared to the control group supporting the notion that contact lenses 
initiate a hypoxic response. The lack of change in SO2 in either group supports the theory of 
vasoregulation. 
7.2 Introduction 
Oxygen plays a vital role in supporting the metabolic activity that maintains corneal health. An 
adequate amount of available oxygen is one of the primary requirements for healthy eyes and 
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consequently, successful contact lens wear.
1
 Various changes in the cornea associated with 
hypoxia have been observed by clinicians since the advent of contact lens wear.
1
 Symptoms are 
reported to be complex and dynamic and have included redness, dryness and discomfort.
1
 Long-
term daily wear of contact lenses can cause ocular changes including corneal swelling, vascular 
changes, refractive changes and corneal epithelial changes.
2
 
It has been reported and hypothesized that ocular inflammation associated with contact lens wear 
is associated with oxygen availability and produces key signs and symptoms that include 
redness, swelling, and pain.
1,3
 Cytokines, growth factors, and matrix degrading enzymes play an 
important role in ocular inflammation.
4
 Acute red eye is one form of an ocular inflammatory 
response that produces significant patient discomfort, pain, and photophobia with corneal 
hypoxia being at least a contributing factor and possibly further stimulating the response.
2,5-7
 
Prolonged hypoxia may result in infiltration and new vessel growth.
2
 The ocular redness 
response to contact lens wear is therefore of considerable importance. 
The development of new vessels into the cornea (corneal neovascularization) from the limbal 
vasculature is stimulated by hypoxia.
8,9
 This vascularization as a result of contact lens wear was 
proposed to initiate inflammation and the release of various inflammatory cells.
10
  
The surfaces of the contact lens interact with the palpebral conjunctiva, corneal surface and 
bulbar conjunctiva and thus, in addition to the metabolic effects of the contact lens on the corneal 
surface, there is also the potential for mechanical or toxic effects. Mechanically the lens may 
exert excessive negative pressure on the cornea
11
 through altered surface properties or produce 
localized dehydration-type corneal staining.
12
 Toxic adverse effects are produced through the 
unwanted accumulation of corneal epithelial by-products between the contact lens and cornea.
13
  
The adverse effects described all have the potential to produce an inflammatory response of the 
anterior ocular segment ultimately causing vasodilation and the circulation of inflammatory 
mediators, initially leading to hyperemia.
14
  It has been hypothesized that if the majority of the 
redness is limbal and localized, the contributing factor is of corneal origin and if the redness is 
diffuse the contributing factor is bulbar.
15
 
Silicone hydrogel (SH) contact lenses transmit more oxygen to the eye than conventional 
hydrogel lenses,
16





clinical performance of SH lenses is better compared to lenses with a lower oxygen permeability 
(low Dk) on a number of physiological markers.
17,19
 Improvements in ocular health have been 
reported in all corneal layers as well as in the conjunctival response to lens wear.
20-23
 Silicone 
hydrogel lenses should therefore sustain or improve the corneal health of contact lens patients 




A few studies have compared SH lenses with low Dk disposable hydrogels and have 
demonstrated that SH lenses allow for healthier corneas which may provide greater resistance to 
inflammation or infection.
26-29
 Therefore, the risk of corneal inflammatory rates should 
theoretically be reduced in those wearing SH lenses compared to traditional hydrogels.
27-29
 
Recent reports have acknowledged that although SH lenses have eliminated lens-induced 
hypoxia for the majority of wearers and ocular health benefits of silicone hydrogel lenses have 
increased the length of time these lenses can be worn overnight, the risk of infection is similar to 
that found with other soft lens types. 
30-33
 A consensus amongst practitioners is that a 
comprehensive understanding of how SH lenses interact with the corneal surface, upper eyelid 




By measuring red blood cell velocity, oxygen saturation and ocular surface redness in the 
conjunctival vessels of habitual contact lens wearers, we are able to study the changes that occur 
in the circulation and the levels of oxygen delivery and saturation.  
This study is novel in that these three parameters have never been measured in contact lens 
wearers. By comparing these values to those of individuals who do not wear contact lenses, we 
will perhaps be able to elucidate the effect that a contact lens has on these ocular surface 
parameters.   
7.3 Hypothesis 
The hypothesis of this study was that the participants who wore contact lenses on a regular basis 
would have an increased red blood cell velocity, decreased oxygen saturation and an increased 
ocular surface redness when compared to the group of subjects that did not wear contact lenses. 
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7.4 Materials and Methods 
7.4.1 Sample 
Ethics clearance was obtained through the Office of Research Ethics at the University of 
Waterloo before commencement of the study. Eligible subjects signed an informed consent 
document before enrolment in the study.  
The eligibility of participants was determined at a screening appointment. The sample consisted 
of 11 healthy participants (control group) who did not wear contact lenses with an average age of 
34.5 years (range 24-57 years) and 11 healthy participants (study group) who habitually wore 
contact lenses with an average age of 32.3 years (range 23-55 years). Lens type and care regimen 
used by each study participant are shown in Table 7-1. Participants in the study group wore their 
contact lenses for on average 11.2 hours/day, 5.7 days/week (silicone hydrogel sub sample: 12.1 
hours/day, 6.3 days/week; hydrogel sub sample: 10.2 hours/day, 5.0 days/week). Subjects with 















Table 7-1: Lens type and care regimen used by each study participant 
Study Participant (Silicone 
Hydrogel Group) 
Lens Brand Lens Care System 
1 Focus Night & Day Opti-Free Express 
2 Acuvue OASYS Clearcare 
3 Acuvue OASYS Opti-Free Express 
4 Acuvue OASYS Clearcare 
5 Acuvue OASYS Opti-Free Express 
6 Acuvue OASYS Opti-Free Express 
Study Participant (Hydrogel 
Group) 
Lens Brand Lens Care System 
1 Proclear Clearcare 
2 Acuvue Moist Dailies n/a 
3 Acuvue 2 Clearcare 
4 Biomedics Dailies n/a 
5 Acuvue Moist Dailies n/a 
 
 
7.4.2 Redness Measurements 
Please refer to chapter 5.4.2 of this thesis for redness measurement description. 
7.4.3 Blood Oxygen Saturation Measurements 
Please refer to chapter 4.3.3 of this thesis for blood oxygen saturation measurement description. 
7.4.4 Red Blood Cell Velocity Measurements 




The participants‟ temporal conjunctiva was viewed with the slit lamp and a vessel was chosen as 
the “vessel of interest” (VOI) and was used for all subsequent measurements. 8 measurement 
sessions, 1 hour apart, began at 9:00am. The study group was instructed to wear their habitual 
contact lenses on the day of measurements.  
7.4.5.1 Redness Measurement Procedures 
Please refer to chapter 5.4.5.1 of this thesis for redness measurement procedure description. 
7.4.5.2 Blood Oxygen Saturation Measurement Procedures 
Please refer to chapter 5.4.5.2 of this thesis for SO2 measurement procedure description. 
7.4.5.3 Red blood cell velocity measurement procedures 
Please refer to chapter 5.4.5.3 of this thesis for RBC velocity measurement procedure 
description. 
7.4.5.4 Data Analysis 
The control group and study group were assessed for differences across the 8 visits for all three 
measures using a mixed ANOVA (Statistica 7; Statsoft, Tulsa, OK).  
7.5 Results 
7.5.1 Control and Study Group Comparisons 
7.5.1.1 Redness Measurements 
The mean redness over time (mean ± SD) ranged from 0.270 ± 0.006 to 0.272 ± 0.006 for the 
control group and 0.271 ± 0.007 to 0.274 ± 0.010 for the study group. There was no effect of 
group on redness (F(1,20)=0.67, p>0.05; Figure 7-1). The interaction between group and time on 
redness was significant (F(7,140)=2.52, p=0.02; Figure 7-2). The differences were between visit 
1 and visit 4, 6 and 7 of the control group (Tukey HSD; p=0.05, p=0.05 and p=0.03 respectively) 
and between visit 1 and 7; visit 2 and 7, 8; visit 3 and 5 and; visit 5 and 6, 7, 8 of the study group 
(Tukey HSD; p=0.05; p=0.02, p=0.04; p=0.01; p=0.01, p=0.001, p=0.001 respectively). 
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Redness Stratified by Group
Current effect: F(1, 20)=0.67, p=0.42









































Figure 7-2: Interaction between group and time on redness 
 
 
Current effect: F(7, 140)=2.52, p=0.02
Vertical bars denote 0.95 confidence intervals
 Control
 Study


























SO2 Stratified by Group
Current effect: F(1, 20)=0.87, p=0.36




























7.5.1.2 Oxygen Saturation Measurements 
The mean oxygen saturation over time (mean ± SD) ranged from 98.0 ± 2.5 to 99.2 ± 2.2 for the 
control group and 98.5 ± 1.0 to 99.5 ± 1.6 for the study group. There was no effect of group on 
SO2 (F(1,20)=0.87, p>0.05; Figure 7-3). The interaction between group and time on SO2 was not 





























Figure 7-4: Interaction between group and time on SO2 
 
7.5.1.3 Red Blood Cell Velocity  
The mean RBC velocity over time (mean ± SD) ranged from 16.4 ± 10.8 to 44.6 ± 14.9 for the 
control group and 10.2 ± 14.5 to 27.8 ± 23.1 for the study group. There was an effect of group on 
RBC velocity (F(1,11)=5.77, p=0.04; Figure 7-5). The interaction between group and time was 
significant (F(7,77)=2.68, p=0.02; Figure 7-6). The differences were between visit 8 and visit 1, 
4 and 5 of the control group (Tukey HSD; p=0.0002, p=0.03 and p=0.01 respectively) and 
between visit 8 of the control group and visits 2, 3, 4, 5, and 7 of the study group (Tukey HSD; 







Current effect: F(7, 140)=1.15, p=0.33
Vertical bars denote 0.95 confidence intervals
 Control
 Study






























RBC Velocity Stratified by Group
Current effect: F(1, 11)=5.77, p=0.04

























































Figure 7-6: Interaction between group and time on RBC velocity 
 
Current effect: F(7, 77)=2.68, p=0.02
Vertical bars denote 0.95 confidence intervals
 Control
 Study






































Redness Stratified by Group
Current effect: F(1, 9)=0.28, p=0.61




























7.5.2 Study Group Comparisons sorted by lens type  
7.5.2.1 Redness Measurements 
The mean redness over time (mean ± SD) ranged from 0.272 ± 0.006 to 0.276 ± 0.008 for the SH 
group and 0.270 ± 0.009 to 0. 272 ± 0.001 for the hydrogel group. There was no effect of group 
(F(1,9)=0.28, p>0.05; Figure 7-7). The interaction between group and time on redness was not 






























Figure 7-8: Interaction between group and time on redness 
 
7.5.2.2 Oxygen Saturation Measurements 
The mean oxygen saturation over time (mean ± SD) ranged from 98.6 ± 1.6 to 99.8 ± 1.6 for the 
SH group and 98.1 ± 2.0 to 99.9 ± 1.4 for the hydrogel group. There was no effect of group 
(F(1,9)=0.47, p>0.05; Figure 7-9). The interaction between group and time on redness was not 







Current effect: F(7, 63)=0.45, p=0.87
Vertical bars denote 0.95 confidence intervals
 SiHi
 Hydrogel























SO2 Stratified by Group
Current effect: F(1, 9)=0.47, p=0.51






















































Figure 7-10: Interaction between group and time on SO2 
Current effect: F(7, 63)=0.85, p=0.55
Vertical bars denote 0.95 confidence intervals
 SiHi
 Hydrogel
































RBC Velocity Stratified by Group
Current effect: F(1, 4)=0.11, p=0.76








































7.5.2.3 Red Blood Cell Velocity  
The mean RBC velocity over time (mean ± SD) ranged from 9.3 ± 11.1 to 15.5 ± 17.5 for the SH 
group and 8.1 ± 6.4 to 40.2 ± 28.8 for the hydrogel group.  There was no effect of group 
(F(1,4)=0.11, p>0.05; Figure 7-11). The interaction between group and time on RBC velocity 
was significant (F(7,28)=2.33, p=0.05; Figure 7-12). The significance was between the sixth and 





























Figure 7-12: Interaction between group and time on RBC velocity 
 
7.6 Discussion 
The present study investigated conjunctival redness, RBC velocity and oxygen saturation in a 
group of participants who were not contact lens wearers and a group who were habitual contact 
lens wearers.  
The measurements in this present study were of the bulbar conjunctival vessels. There is a lack 
of information regarding the effects of contact lens wear on the bulbar conjunctiva. However, it 
has been demonstrated that there is a strong association between the hypoxic effects of contact 
lens wear and limbal hyperemia.
34-38
 Vessel dilation associated with contact lens wear has been 
attributed to a decrease in blood velocity and flow, potentially induced by changes in blood 
rheology and metabolic demands.
39
 The chronic level of vessel dilation in soft lens wearers is 




Current effect: F(7, 28)=2.33, p=0.05
Vertical bars denote 0.95 confidence intervals
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Normally, new blood vessel growth is tightly synchronized and usually limited to wound 
healing.
41
 The process is initiated by the release of various growth factors and vasoactive 
molecules.
42
 It is the balance of these naturally occurring stimulators and inhibitors that is 
thought to tightly control the normal metabolism of the vasculature.
43
 When this balance is upset, 
as is possible in contact lens wear, endothelial cells of the blood vessels are stimulated to 
proliferate, migrate, and ultimately differentiate. 
Red blood cell velocity in this experiment was significantly lower in the study group and on 
average, was 36.7% lower than the control group across time. It is sometimes difficult to 
interpret measurements of blood velocity/flow primarily because of the various types of 
instruments used for flow measurement and the differences in the circulation between specific 
ocular regions.
46
 It could be plausible that the contact lens interfered with the availability of 
oxygen at the ocular surface and therefore the changes that occurred could have been as a result 
of the oxygen demands on the tissue. With the interference of available oxygen because of lens 
wear, the vessels would have to accommodate the RBC velocity in order to maintain adequate 
levels of oxygenation to the tissue. Contact lens wear has been demonstrated to be one of the 
initiators in corneal neovascularization.
21,27-29,36
 It has also been documented that these new 
vessels can “empty” and vascularization can decrease when oxygen levels increase again.
32
 The 
significant decrease in red blood cell velocity that was demonstrated could have occurred as a 
result of vessel filling (ghost vessels). With a greater number of vessels (i.e. additional ghost 
vessels) supplying the same blood volume, RBC velocity would be expected to decrease. 
Vascularization is associated with hypoxic stress, and vessels have been shown to “refill” when 
hypoxia is reapplied after having discontinued lens wear.
2
  
Since a decrease in RBC velocity is attributed to vessel dilation in contact lens wearers
39
 
(potentially induced by changes in blood rheology and metabolic demands) and a significant 
decrease in RBC velocity in the study group was shown, an increase in redness was expected.
 
However, no significant difference in redness between groups was demonstrated. Although a 
difference was not found statistically, if the trend evident in Figure 7-1 is correct and there is a 
difference that was not revealed because of the lower power to detect differences in the variables 
then a higher level of bulbar redness in the study group would be evident.  
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There were no significant differences in oxygen saturation between the control and study groups 
or in their interaction. A function of the vasculature is to maintain a constant level of regulation 
during ordinary instances and especially during the times when various stimuli are applied to the 
system, such as during contact lens wear.
42,44,45
 It was demonstrated that even with a significant 
difference in RBC velocity between groups, SO2 levels remained constant and thus supports 
vascular regulation. This regulatory mechanism is necessary to maintain structure and function 
of the tissue when a contact lens is in place.  
It has been reported that when compared to traditional hydrogels, SH‟s provide sufficient 
oxygen, enabling healthier corneas to effectively decrease the effects of  hypoxia and decreasing 
complications associated with acute and chronic oxygen deprivation.
21,48,49
 Because of high 
oxygen transfer and in addition to high tear elimination rates that enhance the removal of 
potentially antigenic postlens debris, SH lenses are thought to provide a greater resistance to 
inflammation and infection.
26,50
 However regardless of the minimal effects due to hypoxia, 
clinical and adverse complications continue to be reported. These events seem to be related to 
inflammation, infection, trauma, or mechanical disturbances.
48
 There has also been a lack of 
information relating to effects imposed on the bulbar conjunctiva as a result of SH lens wear. 
The studies in the literature refer to increased or decreased redness in the region of the limbus. 
Since there are no studies in the literature that directly measure and compare bulbar redness 
oxygen saturation levels and RBC velocities in SH and hydrogel wearers it is difficult to form 
any conclusions.  
There have been a few ocular response studies that have directly compared SH with low Dk 
disposable hydrogels.
27-29
 With the exception of one of the studies, they all utilized SH lenses for 
up to 30 days continuous wear and low Dk lenses on a 7-day wear schedule and reported a higher 
rate of corneal inflammatory events in the SH group (although the differences compared to low 
Dk lenses were not statistically significant). A meta-analysis by Szczotka-Flynn et al
33
 revealed 
that SH lenses typically worn for up to 30 days extended wear doubles the risk of corneal 
inflammatory events when compared with low Dk lenses when typically worn for 7 days of 
extended wear. It was concluded in that study that the increase in risk associated with corneal 
inflammatory events cannot be definitively linked to SH lens materials since the effect of 
material on the outcome is confounded by length of wear.
33
 Although the participants in the SH 
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group of this present study reported wearing their lenses on average 1.9 hours/day and 1.3 
days/week more than the hydrogel group, this most likely had no effect on the outcome of the 
measures. It has also been reported that long-term clinical performance of SH worn for 6- or 30-
nights continuously was similar and that the clinical markers of hypoxia were low in both groups 
(regardless of wear schedule), with respect to the prevention of lens spoilage, the improvement 
of corneal physiology and the subjective symptoms of comfort and vision.
51
  
A paper by Stapleton et al
32
 re-iterated the points about ocular physiological improvements that 
are documented with the use of highly oxygen transmissible SH materials including relatively 
low severity levels of corneal inflammatory events. The authors go on to state that many of the 
infiltrates involved in the inflammatory events are “asymptomatic” and possibly caused by a 
normal ocular response to the environment. It should be noted that the results of this present 
study regarding redness, SO2 and RBC velocity measurements are different to the studies in the 
literature
2,21,28,32,32,48,52
 in that the measurements were taken on the bulbar conjunctiva, whereas 
the literature reports inflammatory events occurring in the limbal and corneal regions. Although 
decreases in limbal redness
53,54
 and inflammatory response in the cornea
36
 are reported, perhaps 
more attention should be focused on the bulbar area of the conjunctiva since this present study 
indicates trends for redder eyes, higher levels of circulating oxygen and lower RBC velocities, 
possibly suggesting an ocular response, whether inflammatory, mechanical or toxic. 
Although differences were not found statistically, if the trends evident in Figures 7-7, 7-9 and 7-
11 are correct, and there are differences that were not revealed because of the lower power to 
detect differences in the variables then, higher levels of bulbar redness, higher circulating levels 
of oxygen and lower RBC velocities in the SH group would be evident. These trends, if found 
could possibly indicate a greater level of inflammation
28,32-33 
or increased mechanical effects
48
 
and an impaired ability to extract available oxygen compared to hydrogel wearers. 
Again, if the trends are correct, the results of the present study in general (control vs. study) 
demonstrated that the study group had increased ocular surface redness and decreased RBC 
velocities when compared to the control group. Both groups did not demonstrate any significant 
changes in SO2 over time. These findings at the very least suggest influences of hypoxia related 
changes in the study group and support the theory of regulation. The effects, beneficial or not, 
imposed on the rest of the vasculature and the bulbar conjunctiva by new materials remains to be 
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elucidated. Since adverse complications continue to be reported with the use of newer materials 
and may possibly be related to inflammation, infection, trauma, or mechanical disturbances,
 48
 
furthering these findings in a much larger cohort of healthy individuals would prove beneficial. 
7.7 Conclusions 
In summary, the participants in the study group were habitual contact lens wearers that had lower 
RBC velocities when compared to the control group supporting the notion that contact lenses 
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8. General Discussion 
Research related to ocular blood flow and hemodynamics represents a significant opportunity for 
us to make discoveries relating to the basic mechanisms involved in the healthy eye and more so 
in underlying diseases and disorders, whether ocular or systemic. The eye is a unique structure 
because it is one of the few locations in the body where we can non-invasively monitor blood 
flow in the microvasculature. The blood that flows through the arterioles of the bulbar 
conjunctiva represents a valid sample of the mechanical composition of the blood in all of the 
arterioles in the body and, in addition, the reactivity of the vessel walls are similar to the 
reactivity of the vessels present in the connective tissue. In healthy eyes, autoregulation keeps 
blood flow constant, only increasing or decreasing it in response to metabolic demands. 
However, a better understanding of the normal vascular physiology of the eye and its changes in 
disease is required. We do not yet know many of the mediators of blood flow in the various 
ocular beds, or what role they may play in disease. There is a lack of information surrounding the 
anterior surface and its hemodynamics in healthy people. This lack is in part due to the 
unavailability of real-time research tools and methodology to non-invasively quantify 
microvascular parameters. 
The image analysis approach to the assessment of RBC dynamics enables us to visualize and 
quantify a number of important hemodynamic parameters simultaneously. Since the methods are 
based on the analysis of recorded video images, simultaneous results can be obtained from other 
capillaries in the same field of view. Ultimately we can have the means of evaluating oxygen 
supply and oxygen extraction in individual capillaries and capillary networks. 
One of the major objectives of this work was to design a system that could track individual red 
blood cells as they travel through capillaries, thereby allowing analysis of hemodynamic and 
oxygenation parameters of RBC‟s over time and position. In Chapter 3, we established a high 
magnification camera system that was used to capture videos for the assessment of ocular 
capillary hemodynamics. Using signal displacement estimation through DTW algorithms, mean 
red blood cell velocity was estimated. In order to evaluate the performance of the algorithm, a 
simulation representing moving RBCs within a vessel was created. Successful application of the 
algorithm in the estimation of RBC velocity in conjunctival vessels was demonstrated. Signal 
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displacement estimation demonstrated very good concordance to the actual velocities supporting 
its validity.  
Chapter 4 detailed the second application of this technique. Utilizing two specific narrow band 
interference filters with O2-sensitive and O2-insensitive peak transmissions during video capture 
allowed us the ability to calculate and assess haemoglobin oxygen saturation values. This 
technique had been used and demonstrated in the retina, but was novel to the anterior surface. 
Using an extension to this technique and applying it to the anterior surface, we were able to 
measure conjunctival vessel SO2. The intraclass correlations between location measured and 
across consecutive frames on a single vessel for a series of subjects confirmed the reliability of 
the method. The application of the dual wavelength method was subsequently demonstrated with 
the use of a sequential re-breathing technique. Using this technique, we administered elevated 
levels of O2 while controlling PETCO2 and measured SO2 with three different methods; dual 
wavelength method, ear-clip pulse oximetry and finger-clip pulse oximetry. A significant 
increase in oxygen saturation on initiation of hyperoxia with all three measurement methods was 
demonstrated with a subsequent return to initial values when hyperoxia was discontinued. The 
values from the dual wavelength method and the ear clip pulse oximeter were compared to assess 
the validity of the dual wavelength method. When the two methods were compared, no 
significant difference was found. This study was novel in that it utilized an isocapnic hyperoxic 
stimulus to provoke conjunctival vascular reactivity while controlling PETCO2. By controlling the 
compounded vasoconstrictive effects when a reduction in systemic PCO2 occurs, the utility of 
the dual wavelength method was demonstrated with significant changes between effect and 
recovery. The ability to determine changes in SO2 in normal eyes has the potential of an 
application in disease and before and after interventions to aid in the understanding of the effects 
of metabolism or blood flow changes on vascular function. These measurements were proven to 






Table 8-1: Summary of results from chapters 5-7 
 
A summary of the following results are shown in Table 8-1. The results in the “between group” 
column display (if applicable) the hypothesis, statistical result and trend relative to the group (in 
bold and underline font) in the “N” column.  Having developed the two methods that accurately 
assessed red blood cell velocity and oxygen saturation, the purpose of Chapter 5 was to 
characterize the change in conjunctival red blood cell velocity, oxygen saturation and bulbar 
conjunctival redness in a group of clinically normal subjects. An ancillary question was to 
examine these measures in an older age stratum as well as a younger age stratum and to compare 
differences between the groups. The results of this study support the theory of regulation. The 
lack of any significant change across time for redness and oxygen saturation along with 
significant changes in red blood cell velocity substantiates this notion. We were not able to show 
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significant differences between age strata and this was most likely due to the small size of our 
cohorts used. If the trends between the age strata are real, those in the older stratum were shown 
to have redder eyes with lower RBC velocities.  It is known that aging, disease, or a prolonged 
vascular stress alters the normal vessel anatomy or reactivity in various ways and these results 
indicate a loss of vascular reactivity in older patients. Furthering these findings in a much larger 
cohort of healthy individuals would prove beneficial.  
Chapter 6 of this thesis demonstrated the validity of the two measurement techniques after the 
instillation of a topical vasoconstrictor onto the ocular surface of clinically healthy individuals. 
This study also supports the literature regarding regulation of the microvasculature during the 
use of various stimuli. The results demonstrated that oxygen saturation levels remain stable even 
when a significant decrease in ocular redness is measured. The novel techniques used in this 
experiment demonstrated the expected action of the decongestant further contributing to their 
application and validity. 
Chapter 7 evaluated the effect of conventional contact lens wear on red blood cell velocity, 
oxygen saturation and ocular surface redness in subjects with a history of contact lens wear 
compared to subjects that did not have a history of contact lens wear. Although no significant 
difference for redness between groups was found, there was a trend showing that the study group 
had consistently redder eyes than the control group across measures. This finding, if real, was 
consistent with previous studies in the literature. RBC velocity was found to be significantly 
different between groups with the study group demonstrating lower velocities across all 
measures suggesting the occurrence of vessel dilation, growth and/or vessel filling (ghost 
vessels). The participants in the study group were habitual contact lens wearers that had lower 
RBC velocities when compared to the control group supporting the notion that contact lenses 









Table 8-2: Sample power calculations 
  
As alluded to in previous experimental chapters and raised by members of my examining 
committee, a summary of power sample calculations for non-significant factors are shown in 
Table 8-2. A post-hoc power analysis (G*Power 3.0.10; Universitat Kiel, Germany) was 
computed using paired t-test comparisons (α-level of 0.05). If the respective comparisons (as per 
each study) are statistically different, Table 8-2 shows that there is a requirement for either a 





8.1 Future Work 
Future work should investigate the vascular reactivity response of healthy patients in 
substantially larger groups. Further to the confirmation of significant findings relating to vascular 
regulation, studies involving patients with vascular disorders or diseases should be investigated. 
Under normal circumstances, the blood oxygen saturation remains fairly stable because the 
vessels regulate regional blood flow to accommodate changes in perfusion and arterial 
oxygenation (acute changes). During cases of vascular dysregulation (chronic changes), 
regulation does not occur according to the needs of the tissue. Dysregulation occurs when there 
is an underlying disease present or even as a result of an inborn tendency to respond differently 
to a variety of stimuli (e.g. changes in temperature). The occurrence of a disturbed autoregulation 
will lead to an unstable blood flow and since several systems are involved in regulation, the clear 
dysfunction of one of the systems would lead to compensation by another. Investigation of 
vascular reactivity in patients with vascular anomalies (e.g. diabetes) or with the use of various 
stimuli (e.g. different contact lens materials) may also provide more functional information about 
the pathophysiology of the microvasculature on the anterior ocular surface. 
 
 
 
 
